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 Abstract 
The overall aim of this dissertation is to better understand the dynamic matching between 
O2 delivery and uptake following the onset of exercise.  The first study of this dissertation 
(Chapter 2) revealed that: i) the dynamics of muscle oxygenation were determined primarily by 
the Q
.
O2–V
.
O2 interaction during the initial phase of Q
.
O2 response (first 15-20 s); and ii) absolute 
values in the steady state used to calculate blood flow from V
.
O2 and O2 extraction did not affect 
the dynamics of blood flow response.  Consistent with these predictions, using pulmonary gas 
exchange and near-infrared spectroscopy in humans (Chapter 3) we observed that the estimated 
kinetics of capillary blood flow (moderate exercise 25.4 ± 9.1 s and heavy exercise 25.7 ± 7.7 s) 
were not significantly different from the kinetics of muscle V
.
O2 (moderate exercise 25.5 ± 8.8 s 
and heavy exercise 25.6 ± 7.2 s).  In Chapter 4 we observed that nitric oxide (NO) is essential to 
maintain microvascular O2 pressure (PO2mv ∝ Q
.
O2/V
.
O2) of contracting rat muscles.  Blockade 
of NO synthase with L-NAME accelerated the kinetics [ΔMean response time(L-NAME–CONTROL) = 
-6.5 ± 6.6 s, P< 0.05] and reduced the contracting steady-state PO2mv [ΔPO2mv(L-NAME–CONTROL) 
= -5.0 ± 1.0 mmHg; P < 0.05] compared to control.  In Chapter 5 we focused on the kinetics of 
bulk limb blood flow (LBF) to show that a low-pass filter (LPFILTER) developed for LBF data 
improved the confidence of kinetic analysis by decreasing the standard error of the estimate 
(SEE ∝ 95% confidence interval) for all kinetics parameters compared to the Beat-by-Beat 
method (e.g., time-constant phase 2: Beat-by-Beat = 16 ± 5 s; LPFILTER = 1.1 ± 0.5 s).  In 
conclusion, the early increase in Q
.
O2 is the main determinant of muscle oxygenation dynamics 
and NO is essential to maintain the tight coupling of Q
.
O2 and V
.
O2 kinetics during exercise.  In 
this context, application of a LPFILTER to LBF data provides the best confidence for kinetic 
analysis of bulk Q
.
O2 that should facilitate investigations integrating bulk and microvascular      
Q
.
O2/V
.
O2 matching in a variety of settings in health and disease. 
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CHAPTER 1 - Introduction 
 
On a daily basis humans and animals perform activities that are of relatively short 
duration within a wide range of exertion intensity.  These require an increase in oxygen uptake 
(V
.
O2) to meet the metabolic demands of the contracting muscles.  Specifically, following the 
onset of exercise, the requirement for adenosine triphosphate (ATP) increases immediately to a 
new (higher) steady state whereas muscle V
.
O2 (oxidative phosphorylation) increases 
monoexponentially reaching a steady state within 30 to 300 s depending on the species, age, 
training and health status (Jones & Poole, 2005).  The conventional wisdom is that the kinetics of 
V
.
O2, by determining the size of the O2 deficit and reliance on finite nonoxidative energy sources 
[e.g., glycolysis and phosphocreatine (PCr)], has a direct impact on exercise tolerance.  Given 
the burden of chronic diseases characterized by severe exercise intolerance – diabetes, chronic 
obstructive lung disease, chronic heart failure and cancer to mention just a few – the 
understanding of what factors limit the kinetics of V
.
O2 is of relevance not only to basic and 
applied physiology but also to medical practice and improvement of the quality of life of many 
patients (Jones & Poole, 2005).  
 The increase in V
.
O2 depends on O2 being delivered at a sufficient rate by adjustments 
that occur in the cardiovascular and pulmonary systems.  Several studies have demonstrated that 
the kinetics of V
.
O2 are not limited by bulk O2 delivery (Q
.
O2) in healthy young individuals and 
isolated muscles (e.g., Grassi et al. 1998; Bangsbo et al. 2000; Behnke et al. 2002; Burnley et al. 
2002; Koga et al. 2005), but many investigators have been skeptical with regard to these 
conclusions because whole-limb/muscle measurements do not reflect events occurring at the 
capillary-to-myocyte interface where gas exchange takes place.  In recent years technological 
advances facilitated assessment of Q
.
O2-to-V
.
O2 matching in the skeletal muscle microcirculation 
of humans [near-infrared spectroscopy (Bellardineli et al. 1997; DeLorey et al. 2003; Grassi et 
al. 2003)] and rats [phosphorescence quenching (Rumsey et al. 1988; Poole et al. 1995; Behnke 
et al. 2001].  In general, investigation of the dynamic balance between Q
.
O2 and   V
.
O2 in the 
microcirculation confirmed the predictions from bulk measurements, i.e., Q
.
O2 did not limit the 
kinetics of V
.
O2 following the onset of exercise.  However, in chronic diseases and aging a 
different scenario emerged suggesting derangements in convective and diffusive O2 transport as 
primary mediators of slowed V
.
O2 kinetics (Diederich et al. 2002; Behnke et al. 2002b, 2005; 
DeLorey et al. 2004a).  Thus, there has been growing interest in studying the dynamics of  
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muscle O2 exchange to gain insights into the impact of diseases and the mechanisms of Q
.
O2-V
.
O2 
matching.  However, advances in the field have been hindered by a poor understanding of how to 
interpret the dynamics of O2 exchange.  In this context, we developed the study described in 
Chapter 2 to clarify how Q
.
O2 and V
.
O2 interact to determine the dynamic profile of estimated O2 
extraction (near-infrared spectroscopy in humans) and microvascular O2 pressures (PO2mv; 
phosphorescence quenching in rats).  Moreover, this study formed the theoretical basis for the 
investigation presented in Chapter 3, where we propose a new method to estimate noninvasively 
the kinetics of muscle capillary blood flow in humans. This method will permit large-scale 
assessment of microvascular Q
.
O2 in exercising humans to examine dysfunction and 
effectiveness of therapies. 
Several mechanisms have been proposed to explain the increase in blood flow following 
the onset of exercise including a muscle-pump effect, metabolite-induced vasodilation, nitric 
oxide (NO), prostaglandins and ATP among others (Clifford & Hellsten, 2004).  Pathological 
profiles of PO2mv have been demonstrated in conditions associated with diminished endothelial 
NO production suggesting an important role for NO on PO2mv, which is directly proportional to 
the Q
.
O2-to-V
.
O2 ratio.  In the context of Q
.
O2-V
.
O2 matching, as a support to oxidative 
phosphorylation, NO is a double-edged sword because it might simultaneously elevate muscle 
blood flow and inhibit mitochondrial oxidative phosphorylation.  Human studies addressing this 
issue are controversial (Joyner & Dietz, 1997; Clifford & Hellsten, 2004), but, in many instances 
these are of limited scope because the distress caused by pharmacological and invasive 
interventions necessary to elucidate underlying mechanisms are unethical.  In Chapter 4 we 
examined the role of NO in the dynamics and steady state of muscle oxygenation using the 
exposed rat spinotrapezius muscle.   
The controversy surrounding the mechanisms of blood flow regulation is, in part, due to 
the fact that these studies have focused on the steady state of contractions.  Since the various 
vasodilatory pathways are thought to be redundant, investigation in the steady state is not ideal 
(Laughlin & Korzick, 2001).  Assessment of blood flow dynamics is relevant because it allows 
direct comparison with the kinetics of V
.
O2 to examine the Q
.
O2-V
.
O2 matching and could reveal 
important aspects of control of blood flow that are not evident in the steady state.  For example, 
pharmacological blockade of a pathway essential for the increase in blood flow could slow the 
kinetics with achievement of similar steady states during control and blockade due to redundancy 
of regulatory mechanisms.  However, the low signal-to-noise ratio of blood flow measurements 
with resolution sufficient for kinetics analysis in animals and humans (Doppler ultrasound) have 
limited the assessment of blood flow (and Q
.
O2) kinetics with a confidence interval of parameter 
estimates narrow enough to draw definitive conclusions about blood flow regulation.  In Chapter  
 
 
3
5 we examined the validity and effectiveness of a filtering procedure to reduce the signal-to-
noise ratio and accentuate the underlying kinetics of blood flow.  This should facilitate 
development of studies aiming to elucidate the mechanisms controlling blood flow (kinetics) 
during exercise and derangements in aging and/or chronic diseases. 
Therefore, the studies described herein were designed to further our understanding of the 
Q
.
O2-V
.
O2 matching following the onset of exercise.  Each chapter is self-contained following the 
standard journal article format (Introduction, Methods, Results, Discussion and Conclusions), 
whilst only one set of references was included in the end of the dissertation to avoid repetition. 
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CHAPTER 2 - Muscle blood flow - O2 uptake interaction and their 
relation to on-exercise dynamics of O2 exchange 
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Summary 
 
A computer model was developed to provide a theoretical framework for interpreting the 
dynamics of muscle capillary O2 exchange in health and disease. We examined the effects of 
different muscle oxygen uptake (V
.
O2m) and CvO2 profiles on muscle blood flow (Q
.
m) kinetics 
(Q
.
m = V
.
O2m/[CaO2  CvO2]). Further, we simulated V
.
O2m and Q
.
m responses to predict the CvO2 
profile and the underlying dynamics of capillary O2 exchange (CvO2 = CaO2  V
.
O2m/Q
.
m). 
Exponential equations describing V
.
O2m, CvO2 and Q
.
m responses in vivo were used in the 
simulations. The results indicated that Q
.
m kinetics were relatively insensitive to CvO2 
parameters, but directly associated with V
.
O2m kinetics. The biphasic Q
.
m response produced a 
substantial fall in CvO2 within the first 15-20 s of the exercise transition (phase 1 of Q
.
m). These 
results revealed that the main determinant of CvO2 (or O2 extraction) kinetics was the dynamic 
interaction of Q
.
m and V
.
O2m kinetics during phase 1 of Q
.
m. 
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Introduction 
 
Microvascular (phosphorescence quenching) and tissue (near-infrared spectroscopy, 
NIRS) oxygenation measurement techniques have revealed marked pathological alterations in 
capillary O2 exchange  within the muscle in disease states such as heart failure and diabetes 
(Belardinelli et al., 1997; Diederich et al., 2002; Behnke et al., 2002b). However, interpretation 
of these findings is limited by a lack of understanding of the interrelationships among muscle 
oxygen uptake (V
.
O2m), capillary blood flow (Q
.
m), and O2 extraction [~ venous O2 content 
(CvO2), when CaO2 is constant]. For instance, microvascular PO2 profiles reported in diabetic 
rats (Behnke et al., 2002b) and estimated capillary O2 extraction in older human subjects 
(DeLorey et al., 2004a) suggested a complex relationship between Q
.
m and V
.
O2m that was not 
completely explained by assuming monoexponential Q
.
m and V
.
O2m responses (Barstow et al., 
1990; Behnke et al., 2002a; Diederich et al., 2002). To date, the  CvO2 dynamics following the 
onset of exercise have not been systematically investigated to clarify how V
.
O2m and Q
.
m are 
temporally associated to yield the profiles of O2 exchange previously reported (Behnke et al., 
2002c; Behnke et al., 2003; Diederich et al., 2002).  
Although recognizing that exercise hyperemia has two phases (Shoemaker & Hughson, 
1999), the results from prior studies have been interpreted (Diederich et al., 2002; Grassi et al., 
2003; DeLorey et al., 2004a) and modeled (Barstow et al., 1990; Behnke et al., 2002a) 
considering Q
.
m as a monoexponential response. However, the observed kinetics of muscle blood 
flow are biphasic during rest-exercise (MacDonald et al., 1998; Shoemaker & Hughson, 1999; 
Kindig et al., 2002b) and unloaded exercise-exercise transitions (Koga et al., 2005). 
Interestingly, simulations of V
.
O2m and CvO2 kinetics (similar to observed PO2mv or O2 extraction 
profiles) to predict the time course of  Q
.
m in the present study did not result in the noticeable 
two-exponential Q
.
m response described in previous studies (see Results from Section I). 
Therefore, to investigate which CvO2 (or O2 extraction) profile would be associated with a 
biphasic Q
.
m response (MacDonald et al., 1998; Kindig et al., 2002b; Koga et al., 2005), we 
extended previous modeling studies (Barstow et al., 1990) by simulating a two-exponential Q
.
m 
response along with a monoexponential V
.
O2m (Section II). We predicted that this would yield 
new insights into those mechanisms underlying the dynamics of O2 exchange in the 
microcirculation. 
Thus, the present study was undertaken to provide a solid theoretical foundation from 
which to explore the mechanistic bases for physiologic and pathologic observations of 
microvascular PO2 and tissue oxygenation. The study was divided into two sections. In the first 
section our aim was to estimate the Q
.
m dynamics necessary to produce a given CvO2 profile, as  
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implied from previous reports of PO2mv and deoxyhemoglobin ([HHb], by NIRS) kinetics 
(Behnke et al., 2002c; Diederich et al., 2002; Grassi et al., 2003; DeLorey et al., 2004a). In 
addition, these simulations would provide the basis for estimating the kinetics of muscle 
capillary blood flow based on noninvasive estimates of V
.
O2m and microcirculatory O2 extraction 
kinetics {i.e. [HHb] (t)}, which is an important step that has not, as yet, been performed (Grassi 
et al., 2003; DeLorey et al., 2004a). In the first section of this study a biphasic Q
.
m response was 
not detected reliably by nonlinear regression analysis, therefore, the second part was designed to 
extend previous computer modeling studies (Barstow et al., 1990; Behnke et al., 2002a) by 
simulating a two-exponential Q
.
m response in order to investigate the resulting CvO2 (O2 
extraction) profile. 
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Methods 
 
Model:  In Section I the model was designed to simulate V
.
O2m and CvO2 responses to 
study the independent effects of their kinetic parameters on Q
.
m kinetics. Exponential equations 
describing  V
.
O2m and O2 extraction (Barstow et al., 1990; Grassi et al., 1996) or PO2mv (Behnke 
et al., 2002a) observed in vivo were used in the simulations. For V
.
O2m the equation was 
 
   V
.
O2m = V
.
O2(BSL) + A·(1 –e
-t/τ)    (1) 
 
where BSL is baseline; A, amplitude and τ, time constant of response. Similarly, CvO2 was 
described as 
 
   C v O 2 = CvO2(BSL) - A· (1 – e
-(t-TD)/τ) (2) 
 
where TD is time delay and BSL, A, and τ are as defined above. A more complex equation was 
also included to generate CvO2 profiles with overshoots (OS) and/or undershoots (US) to 
replicate patterns reported in health (Grassi et al., 1996; Behnke et al., 2002a) and disease 
conditions (Diederich et al., 2002), respectively. To obtain smooth CvO2 responses and closely 
approximate in vivo profiles we used a double exponential equation. Specifically, 
 
  C v O 2 = CvO2(BSL) + Au· (1 - e
-(t-TD)/τu)     upward component        (3) 
    -   A d· (1 - e
-(t-TD)/τd)   downward  component 
 
where subscripts (u) and (d) represent the upward and downward components, respectively. 
Overshoots will be observed when the time course of the upward component is faster than the 
downward component (τu < τd) while undershoots will be determined by a downward component 
occurring faster than the upward response (τd < τu). For overshoots and undershoots, Ad > Au and 
the steady state amplitude will be equal to Ad - Au (see Appendix for exact values). The initial 
parameter values used in the simulations were obtained from published data. Specifically, 
baseline and steady state values of V
.
O2m and CvO2 were taken from those reported by 
Richardson et al. (Table 2 in Richardson et al., 1993) for knee extension exercise, whereas the 
kinetic parameters for V
.
O2m and CvO2 (O2 extraction) were equivalent to V
.
O2p (phase 2) and 
deoxy-Hb/Mb (or [HHb] as used herein) reported by Grassi et al. (2003). The values used for 
CvO2 (TD and τ) are also consistent with the results obtained in a dog gastrocnemius preparation 
(Grassi et al., 2002). The default values are shown in Table 2.1. Simulations were accomplished  
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by varying one kinetic parameter (τ or TD) of V
.
O2 or CvO2 while keeping the remaining values 
in the default condition. On the other hand, amplitudes (A in Eq. 1 and 2) of V
.
O2m and CvO2 
were altered concurrently so that the steady state V
.
O2m to Q
.
m relationship would reproduce the 
data reported for different work rates (Richardson et al., 1993). Muscle blood flow was 
calculated from the resulting V
.
O2m and CvO2 profiles by rearrangement of the Fick equation 
where Q
.
m = V
.
O2/(CaO2 - CvO2).  For all situations CaO2 was assumed to be 20 ml O2·100 ml
-1 
and constant. The resulting Q
.
m response was fitted by a monoexponential model using nonlinear 
regression procedures (Sigma Plot 2001, Jandel Scientific) where 
 
   Q
.
m = Q
.
m (BSL) + A1· (1 - e
-(t-TD)/τ)    (4) 
 
where BSL, A, τ and TD are defined above. A double exponential fitting was not justified 
because an exponential phase 1 response was not reliably discerned either by the curve fitting 
computer routine with analysis of residuals, or by visual inspection.    
In Section II we simulated Q
.
m and V
.
O2m to investigate the resulting CvO2 profile. This 
section extended previous simulations (Barstow et al., 1990; Behnke et al., 2002a; Diederich et 
al., 2002) by incorporating a physiologically relevant biphasic Q
.
m response (Shoemaker & 
Hughson, 1999; Kindig et al., 2002b). V
.
O2m was again modeled as a monoexponential response 
(Eq. 1) and the Q
.
m response was simulated using a two exponential equation  
 
Q
.
 = Q
.
m(BSL) + A1· (1 - e
-t/τ1)   Phase 1 (5) 
              + A2· (1 - e
-(t-TD2)/τ2)   Phase 2 
 
where BSL is baseline; A, amplitude; τ, time constants and TD, time delay of each phase. 
Subscripts (1) and (2) refer to each phase of the response. Phase 1 was described up to TD2 and 
its observed amplitude calculated as A’1 = A1· (1 - e
-TD2/τ1). In turn, A’1 was manipulated to 
simulate changes in the amplitude of phase 1. In this series τV
.
O2m and τ1, τ2, TD2 and A’1 (as a 
fraction of total amplitude, where Atot = A’1 + A2) for Q
.
m, were varied. The baseline, steady state 
values and default parameters of V
.
O2m and Q
.
m are shown in Table 1. Slightly different values for 
Q
.
m and CvO2, compared to Section I, were used so that a greater CvO2 amplitude could be 
studied allowing better representation and analysis of the data. Unfortunately, detailed 
information regarding Q
.
m kinetic parameters is limited and our choice for default τ1 was based 
on average values of published data (MacDonald et al., 1998; MacDonald et al., 2000; Radegran 
& Saltin, 1998) while τ2Q
.
m was initially set equal to τV
.
O2m and A’1 = 0.4 Atot based on visual 
inspection of Fig. 5 from Grassi et al. (1996). Although these values may not reflect universally  
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the underlying physiological responses, they do provide a standard condition for the modeling. 
Further, the simulations were designed to include the spectrum of conditions likely to be 
observed in vivo.  
CvO2 was calculated from the Fick equation solved for CvO2 where, 
 
                                                                                      (6) 
 
CaO2 was the same as in Section I (i.e., 20 ml O2·100 ml
-1). The resulting CvO2 was then 
fitted by nonlinear regression procedures using Eq. 2 to yield the τ and TD. The resulting CvO2 
profile was not always truly exponential (see Results), but Eq. 2 provides quantitative 
information about the overall temporal profile. However, in some conditions an exponential 
model was not possible. In case of an initial overshoot the portion of the data corresponding to 
values above baseline were ignored in the nonlinear regression procedure.  
For each of the simulations in Sections I and II we assumed a monoexponential increase 
in V
.
O2m from the onset of exercise and a homogeneous muscle compartment represented by a 
single set of parameters (amplitudes, time constants and time delays). Moreover, neither 
diffusion limitation nor the presence of anatomical or physiological shunts was incorporated in 
the simulations. 
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Results 
 
Section I:  The effects of varying the parameters describing CvO2 and V
.
O2m on Q
.
m 
kinetics are depicted in Figures 2.1-2.4. τQ
.
m was not affected (range 28.0 to 28.6 s) by the 
baseline values of CvO2 (range 7.5 to 12 ml O2·100 ml
-1; Fig. 2.1A). The effects of changes in the 
amplitude of CvO2 (ΔCvO2) were also small (Fig. 2.1B); τQ
.
m was 28.3 s when ΔCvO2 = 3 ml 
O2·100 ml
-1 and 26.6 s for ΔCvO2 = 7 ml O2·100 ml
-1. The effects of altered time-related 
parameters for CvO2 are shown in Fig. 2.1C (TD-CvO2) and Fig. 2.2 (τCvO2).  An increase in 
TD from 5 to 15 s led to a small decrease in τQ
.
m from 29 to 27 s, showing that the CvO2 time 
delay had only a minor effect on the overall Q
.
m kinetics. A 5 fold increase in τCvO2 from 5 to 25 
s resulted in only a ~ 4 s decrease in τQ
.
m (Fig. 2.2B and 2.2C). In contrast to the minor effects of 
CvO2 parameter alterations on the resulting Q
.
m kinetics, τQ
.
m was strongly dependent on, but ~ 2 
s faster than, τV
.
O2m (Fig. 2.1D). An alternative interpretation for these results is that CvO2 
kinetics has little effect on the V
.
O2m kinetics, which is primarily affected by the dynamics of Q
.
m 
(but see Discussion). This is consistent with measurements of V
.
O2m and Q
.
m kinetics in humans 
(Grassi et al., 1996) suggesting that V
.
O2m and Q
.
m are closely linked following the onset of 
exercise. 
In health and disease conditions, overshoots (OS) and undershoots (US) in CvO2 (or 
PO2mv) have been reported (Grassi et al., 1996; Bangsbo et al., 2000; Diederich et al., 2002) and 
simulation of these responses yielded interesting results. As expected, undershoots were 
associated with progressively slower τQ
.
m relative to τV
.
O2m (Fig. 2.3). τQ
.
m for the deepest 
undershoot simulated was ~ 6 s slower than in the default condition (no undershoot). The 
surprising finding was that large changes in CvO2 had relatively small effects on Q
.
m kinetics. 
The US simulations included an 8 s time delay for CvO2 and we acknowledge that if TD were 0 
an even greater effect would have been observed (~ 2 s estimated from simulation of TD-CvO2; 
see above). In contrast to what we anticipated, an OS (Fig. 2.4) did not lead to clear biphasic Q
.
m 
responses, and only minor effects on τQ
.
m were again observed. τQ
.
m was only 1.5 s slower in the 
default condition (no overshoot) than when the amplitude of OS was 30% of the baseline CvO2 
(greatest values simulated; Fig. 2.4B). For this data set τV
.
O2m was 30 s and τQ
.
m = 27.1 s (see 
Fig. 2.4C), demonstrating that an overshoot is not an indication that τQ
.
m is substantially (10-15 
s) faster than τV
.
O2m (Barstow et al., 1990). For comparison, in Fig. 2.4 this situation (τQ
.
m 15 s 
faster than τV
.
O2m) is simulated (gray lines in panels B and C). The resulting overshoot, relatively 
long TD-CvO2 (~ 40 s) and slow CvO2 kinetics are not compatible with direct measurements of 
CvO2 (Grassi et al., 1996; Bangsbo et al., 2000; Grassi et al., 2002) or PO2mv kinetics (Behnke et 
al., 2002a). Altogether, these results suggest that Q
.
m kinetics are relatively insensitive to CvO2  
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(i.e., O2 extraction) kinetics. However, stated in the alternative, more physiological direction 
(where CvO2 is the dependent variable and V
.
O2m and Q
.
m are considered independent variables, 
as in Eq. 6), CvO2 is very sensitive to small changes in the relationship of Q
.
m and V
.
O2m kinetics. 
Section II:  In this section a two-exponential muscle blood flow was coupled to the 
default monoexponential V
.
O2m to examine the determinants of CvO2 kinetics. The most striking 
observation was the rapid fall in CvO2 (~ 80%) occurring during phase 1 of the Q
.
m response 
(Figs. 2.5-2.6) as a consequence of the continuing monoexponential increase in V
.
O2m at the time 
when Q
.
m was initially plateauing. As observed in Section I, CvO2 kinetics were very sensitive to 
changes in Q
.
m kinetics, primarily during phase 1 (Fig. 2.5). During phase 2, the effects of Q
.
m on 
the CvO2 profile were most noticeably observed when τ2Q
.
m was slower than τVO2 (Fig. 2.6), 
which resulted in transient undershoots. When fitted by a monoexponential function the overall 
kinetics underwent only minor changes for τ2Q
.
m ranging from 30 to 45 s. When τ2Q
.
m was faster 
than τV
.
O2 by only 5 s (25 vs. 30 s; Fig. 2.6) the CvO2 profile was inconsistent with direct 
measurements (Grassi et al., 1996; Behnke et al., 2002a; Grassi et al., 2002).  
In general, as a consequence of the biphasic Q
.
m, CvO2 (or O2 extraction) did not follow a 
‘true’ exponential profile; however, physiological measurement noise, as in real data, would tend 
to mask this nonexponential characteristic of the response. In fact, direct measurements of PO2mv 
(Behnke et al., 2002a) and estimates of O2 extraction (Grassi et al., 2003) dynamics are 
relatively well described by exponential equations (as in Eq. 2). 
Subsequent simulations revealed that the characteristics of the phase 1 of Q
.
m response 
[time constant (τ1), Fig. 2.5; time delay (TD2), Fig. 2.7; and amplitude (A’1), Fig. 2.8] were the 
main determinants of CvO2 kinetics (both τ and TD). The effect of a slower τ1Q
.
m was that TD-
CvO2 became shorter and τCvO2 became slower (longer) while the equivalent of the mean 
response time (τ + TD) remained reasonably constant (~ 13 s; Fig. 2.5). On the other hand, 
changes in the duration of phase 1 (TD2; Fig. 2.7) had negligible effects on TD-CvO2 but τCvO2 
became progressively slower with decreases in TD2, e.g, increasing the contribution of phase 2 to 
the overall response by 6 s (TD2 from15 to 9 s) resulted in a 15 s slower τCvO2. The effects of 
the amplitude of phase 1 were also appreciable (A’1; Fig. 2.8). In the conditions simulated, when 
the amplitude at the end of phase 1 represented 30% of the overall increase in Q
.
m (i.e., A ’1 = 0.3 
Atot) this resulted in a shorter TD and undershoot in CvO2 which consequently led to faster 
apparent τCvO2. In contrast, A’1 = 0.5 Atot produced a greater overshoot, longer TD and slower 
τCvO2 when compared to the default condition (A’1 = 0.4 Atot). 
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Discussion 
 
The principal novel finding from Section I was that the Q
.
m kinetics were relatively 
insensitive to alterations in the CvO2 parameters but were sensitive to alterations in V
.
O2m 
kinetics. Conversely, from the more physiological perspective (where V
.
O2m and Q
.
m are the 
independent variables, as in Eq. 6), CvO2 kinetics were very sensitive to small changes in the 
relationship between Q
.
m and V
.
O2m kinetics. The main observations from Section II were: 1) The 
fall in CvO2 occurred predominantly during phase 1 of the Q
.
m response (within 15-20 s of 
exercise onset); and consequently 2) Phase 1 parameters of Q
.
m (time constant, amplitude and 
duration), as well as the parameters of V
.
O2m, (i.e., interaction between V
.
O2m and Q
.
m during 
phase 1 of Q
.
m response) were the main determinants of CvO2 (or O2 extraction) kinetics.  
 
Determination of Q
.
m kinetics from V
.
O2m and CvO2 responses (Section I):  The 
simulations here showed that Q
.
m kinetics were directly associated with V
.
O2m kinetics. This 
observation is consistent with a study using cycling as the exercise paradigm (Grassi et al., 1996) 
suggesting that in the transition to cycling exercise the overall kinetics of Q
.
m and V
.
O2m are 
temporally closely linked (MRT Q
.
m ~ τV
.
O2m). This close association may arise, by examination 
of the Fick equation, from the fact that Q
.
m can increase 20-fold from rest (e.g. Radegran & 
Saltin, 1998) whereas over a similar range of metabolic rates O2 extraction may increase only 50-
60 % (e.g. Roach et al., 1999). Thus, under normal physiological conditions increases in V
.
O2m 
through changes in O2 extraction are relatively limited. However, this must not be misinterpreted 
to suggest that the rate of increase in Q
.
m is the factor limiting V
.
O2m kinetics, as previously 
shown (Grassi et al., 1998).   
In investigations of V
.
O2m and Q
.
m responses to exercise an overshoot in CvO2 has been 
interpreted as a faster initial adjustment of O2 delivery compared to utilization (Barstow et al., 
1990; Grassi et al., 1996; Behnke et al., 2002a). We incorporated the CvO2 overshoot in the 
current model and the resulting overall Q
.
m kinetics were indeed faster (~ 2 s) than τV
.
O2m; 
nonetheless, as shown in Fig. 2.4, the CvO2 profile resulting from τQ
.
m =  ½ τV
.
O2m, as previously 
considered (Barstow et al., 1990), was not consistent with direct measurements in humans 
(Grassi et al., 1996; Bangsbo et al., 2000) or animals (Behnke et al., 2002a; Grassi et al., 2002). 
In this circumstance the CvO2 time delay (time from onset of exercise to where CvO2 crossed 
baseline value) was ~ 40 s, whereas shorter time delays are observed in humans (6-10 s; Grassi et 
al., 1996; Bangsbo et al., 2000), dog gastrocnemius (~ 8 s; Grassi et al., 2002) and rat 
spinotrapezius muscle (15-20 s; Behnke et al., 2002a).  
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In the rat spinotrapezius (Behnke et al., 2002a) and soleus muscle (Behnke et al., 2003) 
as well as in the dog gastrocnemius (Piiper et al., 1968; Grassi et al., 2002) the Q
.
m kinetics 
described by a monoexponential fitting is 6-10 s faster than V
.
O2m kinetics, while for the peroneal 
muscle Q
.
m kinetics have been estimated as 3 s faster than V
.
O2m kinetics (Behnke et al., 2003). In 
humans, the Q
.
m kinetics were slightly (2-3 s), but not significantly faster than V
.
O2m kinetics 
(Grassi et al., 1996), consistent with the results from the present study. Multiple factors could 
explain the dissimilarities between human and animal studies, including species differences, 
fibre type characteristics of the muscle investigated (Behnke et al., 2003) and/or the 
experimental protocol which could result in different profiles of Q
.
m phase 1. We used values for 
the kinetic parameters measured during cycling exercise; however, during knee-extension 
exercise (rest-exercise transitions), for instance, phase 1 amplitude may be as high as 0.8 Atot 
(MacDonald et al., 1998) and its time constant appears to be faster than for unloaded exercise-
exercise transitions (Koga et al., 2005).  In the case of rest-exercise transition Q
.
m kinetics (mean 
response time) were faster than V
.
O2m kinetics (estimated from V
.
O2p phase 2) (MacDonald et al., 
1998), possibly due to a greater muscle-pump effect on Q
.
m phase 1 response. 
 
Implications of biphasic Q
.
m response (Section II):  In the transitional phase exercise 
hyperemia is characterized by a biphasic response, with the initial fast phase lasting 15-20 s 
(Shoemaker & Hughson, 1999; Kindig et al., 2002b). The faster O2 delivery during the initial Q
.
m 
phase is thought to result in a CvO2 overshoot (Barstow et al., 1990; Grassi et al., 1996; Behnke 
et al., 2002a). However, in the previous section simulation of CvO2 overshoots did not lead to a 
clear exponential phase 1 of Q
.
m (Fig. 2.4). The question then becomes “Which CvO2 (or O2 
extraction) profile is associated with a biphasic Q
.
m response?” To answer this question we 
extended previous modeling studies (Barstow et al., 1990) by simulating a two-exponential Q
.
m 
response along with the default monoexponential V
.
O2m to study the CvO2 profile. The most 
striking result from this series of simulations was that the overshoot and predominant fall in 
CvO2 occurred within the first 15-20 s (phase 1 of Q
.
m response). In this instance, phase 1 
parameters (amplitude, time constant and duration as TD2) were the main determinants of CvO2 
kinetics (Figs. 2.5, 2.7 and 2.8). In addition, phase 2 kinetics of Q
.
m appeared to be closely linked 
to V
.
O2 kinetics. 
Phase 1 of the exercise hyperemia has a fast time constant (Shoemaker & Hughson, 
1999) that appears to be mediated by a muscle-pump mechanism  (Sheriff et al., 1993; 
Tschakovsky et al., 1996; Sheriff & Hakeman, 2001), which may be potentiated by a rapid 
vasodilation (Hamann et al., 2004b; Tschakovsky et al., 2004); for review see (Tschakovsky & 
Sheriff, 2004). However, these two mechanisms do not explain the biphasic response per se, and  
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the nature of this phenomenon is not clear at present. In microcirculatory preparations, muscle 
contraction leads to localized arteriolar dilation consisting of two distinct phases (Gorczynski et 
al., 1978). Further, a two-exponential increase in red blood cell (RBC) flux through skeletal 
muscle capillaries (Kindig et al., 2002b) indicates that the biphasic response is not an event 
exclusive to large conduit vessels. 
The effects of phase 1 kinetics of Q
.
m on the CvO2 profile were remarkable. A slower 
phase 1 of Q
.
m (longer τ1) resulted in shorter TD-CvO2 (Fig. 2.5) whereas a prolonged duration 
(Fig. 2.7) and diminished amplitude (Fig. 2.8) of phase 1 Q
.
m produced undershoots in CvO2. 
Endothelium-derived vasodilators (e.g. nitric oxide, Sheriff & Hakeman, 2001) and the muscle-
pump are considered to represent important determinants of phase 1. Consistent with this notion, 
the profiles of CvO2 undershoot observed in Figures 2.5, 2.7 and 2.8 are similar to those seen in 
older adults (Fig. 3 in DeLorey et al., 2004a) and animal models of diabetes (Behnke et al., 
2002b) and heart failure (Diederich et al., 2002) that are associated with compromised 
endothelial function (Drexler et al., 1992; Taddei et al., 1995; De Vriese et al., 2000), muscle-
pumping capacity (Shiotani et al., 2002) and impaired capillary hemodynamics following the 
onset of exercise (Richardson et al., 2003). 
The Q
.
m phase 2 response has been thought to involve integrated processes leading to 
vascular smooth muscle relaxation (Shoemaker & Hughson, 1999). In this study we observed 
that when Q
.
m phase 2 began (or emerged), CvO2 had already reached ~ 85% of the steady state 
exercise value (Fig. 2.6). Interestingly, the estimated capillary O2 extraction kinetics ([HHb], by 
NIRS) in humans (Grassi et al., 2003) and visual inspection of Fig. 2 from Grassi et al. (2002) 
for the dog gastrocnemius contracting at 65-70% V
.
O2max reveals a similar response, where more 
than 80% of the adjustment of O2 extraction from the baseline to the exercise steady state was 
achieved within 20-25 s. From the Fick principle, a direct implication of this finding is that the 
kinetics of Q
.
m phase 2 are closely related to the time course of V
.
O2m because under such 
circumstances V
.
O2m and Q
.
m (phase 2) increase in parallel [N.B. As mentioned above, this does 
not mean that Q
.
m is limiting V
.
O2m kinetics (Grassi et al., 1998)]. A different representation of 
this concept is shown in Figure 2.9 by the linear relationship between V
.
O2m and Q
.
m during phase 
2. This figure qualitatively resembles Fig. 5 from Grassi et al. (1996) for moderate cycling 
exercise and, within the parameters of this simulation, indicates that τ2Qm is similar to (± 2-3 s)  
τV
.
O2m. From this figure it is possible to analyze the V
.
O2m-to-Q
.
m coupling in the transitional 
phase especially when distinction between phase 1-2 is difficult or not justified by the curve 
fitting routine as a result of sampling strategies [e.g., one data point at each 3-5 s in the first 30 s 
and every 15-30 s from 30 s to the end of exercise (Behnke et al., 2002a; Grassi et al., 2002)].   
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Contracting skeletal muscle blood flow is controlled by a complex interplay among 
mechanical (muscle pump), neural and chemical stimuli [rev. (Laughlin & Korzick, 2001; 
Clifford & Hellsten, 2004; Thomas & Segal, 2004)]. Rigorous investigation of the role of each 
potential hyperemic mediator on the kinetics of Q
.
m remains to be undertaken. However, the 
theoretical analysis presented herein, as well as inspection of the microvascular PO2 profiles in 
diabetes (Behnke et al., 2002b) and heart failure (Diederich et al., 2002) reveals that the Q
.
m 
increase between ~10 and 30 s (i.e., across the transition between phase 1 and phase 2) is of 
crucial importance. As apparent in Figures 2.3, 2.6-2.8, this is when the venous O2 content (and 
microvascular PO2) typically fall to their lowest points (below the subsequent steady-state values 
in diabetes and heart failure) and O2 flux is most likely to become diffusion limited thereby 
increasing the size of the O2 deficit. Consequently, crucial insights into the mechanistic bases for 
the slowed VO2 kinetics, high O2 deficit and exercise intolerance in diabetes (Regensteiner et al., 
1998) and heart failure (e.g. Hepple et al., 1999) will depend on rapid, high-fidelity Q
.
m 
measurements in the phase 1-phase 2 transition, i.e., ~ 10-30 s following the onset of 
contractions. 
 
Model limitations and assumptions: A potential confounding factor in the interpretation 
of predictions from the current simulations is that we used baseline and steady state values of    
V
.
O2m, Q
.
m and CvO2 determined for knee-extension exercise (Richardson et al., 1993), while the 
kinetic parameters were obtained from cycling exercise (Grassi et al., 2003). However, the 
results from Section I suggest that, within physiological limits, the effects of baseline and 
amplitude of response (or steady state values) for the three variables included in the modeling 
have negligible effects on the kinetics of the response. It is important to note that the default time 
constant of phase 1 of Q
.
m for the simulations of Section II were taken from knee-extension 
exercise where rest-exercise transitions were investigated (MacDonald et al., 1998; MacDonald 
et al., 2000) and phase 1 kinetics are potentially faster (τ1 ~ 4 s) than for unloaded exercise-
exercise transitions (τ1 ~ 8 s; Koga et al., 2005); however, this does not limit the predictions of 
the modeling to rest-exercise transitions because we have performed simulations of τ1 ranging 
from 2 to 8 s (Fig. 5).  
In this study we assumed a monoexponential increase in V
.
O2m following the onset of 
exercise and a homogeneous muscle compartment without addressing the effects of O2 
conductance (DO2) on PO2mv dynamics, where DO2 is a lumped coefficient which includes all 
impediments to the flux of O2 from capillaries to mitochondria [from Fick’s Law V
.
O2 = 
DO2·(PO2capillary -PO2mito)]. In isolated single myocytes (Kindig et al., 2003) and rat skeletal 
muscle with preserved blood supply (Behnke et al., 2002a) V
.
O2 has been shown to increase  
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immediately (no time delay) following the onset of contraction. In humans, phosphocreatine 
kinetics (presumably reflecting V
.
O2m) are monoexponential with no delay (Rossiter et al., 1999). 
These studies support our assumption of monoexponential increase in V
.
O2m without a time delay 
following the onset of exercise. In contrast, skeletal muscle is heterogeneous regarding blood 
flow (Laughlin & Armstrong, 1982) and O2 exchange profile (Behnke et al., 2003). Blood flow 
and Q
.
m-to-V
.
O2m heterogeneity (Whipp et al., 1995) and diffusion limitation (Roca et al., 1989) 
are important determinants of venous O2 content and pressure, while muscle O2 conductance 
(DO2) may affect microvascular PO2 kinetics (Geer et al., 2002). Thus, we acknowledge that the 
current assumptions are likely oversimplifications of the real physiology, but they are a starting 
point to conceptually understand the mechanisms underlying the physiological and pathological 
responses observed in previous investigations.  
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Conclusions 
 
Our computer simulations have demonstrated that the time course (kinetics) of Q
.
m 
estimated from CvO2 (i.e., O2 extraction) and V
.
O2m dynamics (Section I) is relatively insensitive 
to alterations of CvO2 parameters, mainly baseline and steady state values, but is closely related 
to V
.
O2m kinetics confirming empirical observations (Grassi et al., 1996). Interpreted in a 
physiological sense (where V
.
O2m and Q
.
m are considered independent variables), the kinetics of 
CvO2 were very sensitive to minor changes in the relationship between Q
.
m and V
.
O2m kinetics. 
Modeling a biphasic Q
.
m response (Section II) resulted in an initial overshoot and subsequent 
rapid fall in CvO2. This temporal characteristic of CvO2 was the obligatory consequence of an 
ongoing monoexponential increase in V
.
O2m in the presence of an initial rapid increase in Q
.
m 
with subsequent transient plateau at a value inferior to its final steady state response towards the 
end of phase 1 (15-20 s). In this context, the CvO2 response was almost complete (>80%) within 
the first 15-20 s of exercise and the resulting relatively constant CvO2 during phase 2 implied a 
close dynamic coupling of V
.
O2m and Q
.
m in this second phase of the blood flow response up to 
the steady state. It is important to note, however, that the dynamics of muscle oxygen uptake and 
blood flow will affect the temporal characteristics of O2 extraction, whereas the steady state 
value of (CaO2 - CvO2) will be determined by the steady state relationship between V
.
O2m and    
Q
.
m.  
 
Future directions: This study predicts that in the transition to exercise, CvO2 (or O2 
extraction) is very sensitive to subtle changes in the dynamic balance between Q
.
m and V
.
O2m. In 
this context, the [HHb] signal from NIRS (a proxy of O2 extraction; Grassi et al., 2003), and 
PO2mv by phosphorescence quenching (Rumsey et al., 1988; Behnke et al., 2002a) are promising 
techniques to aid in the investigation of Q
.
m kinetics. Specifically, our results lead to the 
following questions: What mechanism(s) determine the amplitude and time constant of phase 1 
of Q
.
m? Are phase 2 and phase 1 distinct responses, i.e., does phase 2 start or emerge at the 
observed time delay of phase 2? What are the mechanisms underlying the time delay of phase 2? 
What dictates the apparent tight coupling between phase 2 Q
.
m and V
.
O2m? and, finally, Which 
specific parameters of the Q
.
m response are changed by interventions such as exercise training 
and pharmacological blockade of vasodilator/vasoconstrictor pathways? The answers to these 
questions are imperative to understanding the control of blood flow following the onset of 
exercise and the Q
.
m, V
.
O2m and O2 extraction profiles observed in states of health and disease. 
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Table 2.1 - Default values of the model parameters. 
  
V
.
O2m Q
.
m CaO2 CvO2 
Section I           
  Baseline 50  400  20  7.5 
  Exercise 810  5226  20  4.5 
  TD -  -  -  8 
  τ 30  -  -  10 
Section II          
  Baseline 50  500  20  10 
  Exercise 810  5400  20 5 
  τ 30  -  -  - 
  τ1 -  4  -  - 
  A'1 -  1960  -  - 
  TD2 -  15  -  - 
  τ2 -  30  -  - 
  A2 -  2940  -  - 
 
V
.
O2m, muscle oxygen consumption (ml·min
-1); Q
.
m, muscle blood flow (ml·min
-1); CaO2, 
arterial oxygen concentration (ml O2·100 ml
-1); CvO2, venous oxygen concentration (ml O2·100 
ml
-1); TD, time delay (s); τ, time constant (s); A, amplitude (see units for each variable). 
Subscripts 1 and 2 denote the phase of Q
.
m response. Dash, parameter not applicable for the given 
variable. Model parameters of Section I were obtained from Richardson et al. (1993) (baseline 
and steady state values) and Grassi et al. (2003) (time delay and time constants). For Section II 
the Q
.
m parameters were estimated from published data (Grassi et al., 1996; MacDonald et al., 
1998; MacDonald et al., 2000). See text for further details.   
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Appendix – Chapter 2 
 
Table 2.2. Parameters used in Section I to simulate undershoots and overshoots of CvO2. 
  Undershoot Overshoot 
TD  (s)  8 8 8  0 0 0 
τu  (s)  40  90  200  5 5 5 
τd (s)  10 10 10  10 10 10 
Au (ml O2·100 ml
-1) 2  2  2  6  10  14 
Ad (ml O2·100 ml
-1) 5  5  5  9  13  17 
  
TD, time delay. τ, time constant; and A, amplitude. Subscripts (u) and (d) refer to upward 
and downward components of Eq. 3. Baseline and steady state values of CvO2 and V
.
O2m 
parameters are shown in Table 2.1 (Methods). From left to right the parameters will yield a 
progressively greater amplitude of undershoot or overshoot. 
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Figure 2.1. Effects of altered venous O2 content and muscle O2 uptake parameters on 
muscle blood flow kinetics in Section I. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Effects of altered venous O2 content (CvO2) and muscle oxygen uptake       
(V
.
O2m) parameters on muscle blood flow (Q
.
m) kinetics in Section I. τ, time constant; TD, time 
delay; BSL, baseline; ΔCvO2, amplitude of change from BSL. In (B) baseline CvO2 was 10 ml 
O2·100 ml
-1, otherwise the parameters are as shown in Table 2.1. τQ
.
m is shown on the same scale 
in A-D to facilitate comparison among conditions. See text for further details. Note the strong 
dependency of τQ
.
m on muscle V
.
O2 kinetics (D), but otherwise relative independency of the 
parameters of the CvO2 response (A-C). 
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Figure 2.2. Effects of altered CvO2 time constant (τ) on blood flow kinetics.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. Effects of altered CvO2 time constant (τ) on Q
.
m kinetics. In this figure Q
.
m 
(shown in C) was determined from simulation of V
.
O2m and CvO2 using the Fick principle. The 
parameters used in A and B (except for τCvO2; given in B) are shown in Table 1. The time 
constants shown in C were obtained by monoexponential fitting. Solid line represents the default 
condition for section I. Note that τQ
.
m is slightly faster than, but similar to τV
.
O2m despite large 
differences in τCvO2.         
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Figure 2.3. Effects of CvO2 undershoot on blood flow kinetics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Effects of CvO2 undershoot on Q
.
m kinetics. The parameters used to simulate 
the responses shown in A and B are given in Table 2.1 (Methods) and Table 2.2 (Appendix – 
Chapter 2), respectively. See legend in Fig. 2.2 for further details. Note that compared to Fig. 
2.2, undershoots in CvO2 are associated with Q
.
m kinetics being slower than V
.
O2m kinetics. 
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Figure 2.4. Effects of CvO2 overshoot on blood flow kinetics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Effects of CvO2 overshoot on Q
.
m kinetics. The parameters used to simulate 
the responses shown in A and B are given in Table 2.1 (Methods) and Table 2.2 (Appendix-
Chapter 2), respectively. Solid lines (gray) in B and C were obtained from modeling both Q
.
m and 
V
.
O2m as monoexponential increases at the onset of exercise where τV
.
O2m = 30 s and τQ
.
m = 15 s 
to illustrate the effects of faster Q
.
m on the CvO2 profile (Barstow et al., 1990; Grassi et al., 
1996). In this situation CvO2 values below baseline were not observed until ~ 40 s. See Fig. 2.2 
for further details. 
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Figure 2.5. Effects of altered phase 1 of blood flow on CvO2 kinetics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. Effects of altered Q
.
m phase 1 time constant (τ1) on CvO2 kinetics. CvO2 was 
determined from simulation of V
.
O2m and Q
.
m using Eq. 6. The parameters used to simulate V
.
O2m 
and Q
.
m (except τ1) are given on Table 1, while τ1 values are shown in B. In C the time delay 
(TD) and time constant (τ) were determined by fitting the response with Eq. 2 (Methods). The 
response is not exponential but TD and τ provide quantitative values with which to analyze the 
effects of Q
.
m phase 1 (B) on CvO2 kinetics. Note that the faster the τ1 for Q
.
m, the greater the 
initial overshoot in CvO2. Solid line represents the default condition for Section II. 
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Figure 2.6. CvO2 profile resulting from alterations in the phase 2 of blood flow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6. CvO2 profile resulting from simulation of a biphasic Q
.
m response with 
varying phase 2 time constant (τ2). Note that when τ2 for Q
.
m is greater than τV
.
O2m there is a 
slight undershoot in CvO2. Also, note that most of the fall in CvO2 occurs within the phase 1 
time period (15 s in this data set). Solid line represents the default condition for Section II. See 
Fig. 2.5 and text for further details.        
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Figure 2.7. CvO2 response to changes in the duration of phase 1 for blood flow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.7. CvO2 response to changes in the duration of phase 1 for Q
.
m. * curve fitting 
did not follow the undershoot (below steady state) portion of CvO2 (monoexponential fitting, Eq. 
2), but the results are shown to demonstrate the effects likely to be observed when fitting is done 
on “real” data under similar conditions. Solid line represents the default condition for Section II. 
For further details and abbreviations see Fig. 2.5. 
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Figure 2.8. CvO2 response to changes in amplitude of blood flow - phase 1 kinetics. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.8. CvO2 response to changes in amplitude of Q
.
m phase 1 (A’1) kinetics. * curve 
fitting did not follow the undershoot (below steady state) portion of CvO2 (single-exponential 
fitting, Eq. 2). For A’1 = 0.2 Atot curve fitting became unfeasible. N.A, not applicable for the 
reasons stated. Solid line represents the default condition for Section II. For further details and 
abbreviations see Fig. 2.5.  
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Figure 2.9. Dynamic coupling between muscle blood flow and oxygen consumption 
following the onset of exercise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.9. Dynamic coupling between muscle blood flow (Q
.
m) and oxygen consumption 
(V
.
O2m) from exercise onset to the steady state. 1) Dotted lines, isopleths of different CvO2 values 
(in ml O2·100 ml
-1), assuming CaO2 = 20 ml O2·100 ml
-1; 2) Dashed line, expected values for 
monoexponential V
.
O2m and Q
.
m increase from the onset of exercise, both with a time constant of 
30 sec (baseline and steady state values as for default condition); 3) Closed circles, simulated 
response (default condition for Section II, Table 2.1; represented by a solid line in Figs. 2.5-2.8); 
Phase 1 and 2 refers to the Q
.
m response but its boundaries are shown on the V
.
O2m axis for 
clarity. This figure qualitatively resembles Fig. 5 from Grassi et al. (1996), where the overall Q
.
m 
kinetics (mean response time) were ~ 2 s faster than V
.
O2m kinetics. Note that the CvO2 response 
is nearly complete during Phase 1. Based on the Fick principle a direct implication of this is that 
Q
.
m phase 2 is closely related to V
.
O2m (as shown by their linear relationship) because under such 
circumstances further increases in V
.
O2m are almost entirely due to increments in Q
.
m, since O2 
extraction (as CvO2) has almost reached its steady state change by the end of Phase 1. 
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CHAPTER 3 - Muscle capillary blood flow kinetics estimated from 
pulmonary O2 uptake and near-infrared spectroscopy 
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Summary 
  
The near-infrared spectroscopy (NIRS) signal (deoxy-hemoglobin concentration; [HHb]) 
reflects the dynamic balance between muscle capillary blood flow (Q
.
cap) and muscle oxygen 
uptake (V
.
O2m) in the microcirculation. The purposes of the present study were to estimate the 
time course of Q
.
cap from the kinetics of the primary component of pulmonary V
.
O2 (V
.
O2p) and 
[HHb] throughout exercise, and compare the Q
.
cap kinetics with the V
.
O2p kinetics. Nine subjects 
performed moderate- (M; below Lactate Threshold, LT) and heavy-intensity (H, above LT) 
constant work rate tests. V
.
O2p (L·min
-1) was measured breath-by-breath and [HHb] (μM) was 
measured by NIRS during the tests. The time course of Q
.
cap was estimated from the 
rearrangement of the Fick equation [Q
.
cap = V
.
O2m/(CaO2 – CvO2)] using V
.
O2p (primary 
component) and [HHb] as proxies of V
.
O2m and (CaO2 – CvO2), respectively. The kinetics of 
[HHb] (τ+TD [HHb]; M = 17.8 ± 2.3 s and H = 13.7 ± 1.4 s) were significantly (P < 0.001) 
faster than the kinetics of V
.
O2 (τP; M = 25.5 ± 8.8 s and H = 25.6 ± 7.2 s) and Q
.
cap (mean 
response time, MRT; M = 25.4 ± 9.1 s and H = 25.7 ± 7.7 s). However, there was no significant 
difference between MRT-Q
.
cap and τP-V
.
O2 for both intensities (P = 0.99), and these parameters 
were significantly correlated (M and H; r = 0.99; P < 0.001). In conclusion, we have proposed a 
new method to noninvasively approximate Q
.
cap kinetics in humans during exercise. The resulting 
overall Q
.
cap kinetics appeared to be tightly coupled to the temporal profile of V
.
O2m.  
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Introduction 
 
Insights on the control of exercising muscle blood flow (Q
.
m) can be gained from the 
investigation of its response in the transitional phase (i.e., kinetics) (Laughlin & Korzick, 2001; 
Hughson, 2003), but due to methodological constraints the kinetics of Q
.
m in humans have been 
studied primarily in larger vessels (Shoemaker et al., 1996b; Shoemaker et al., 1997; Hughson et 
al., 1996; Grassi et al., 1996; MacDonald et al., 1998; Bangsbo et al., 2000; Radegran & Saltin, 
1998).  
The difficulty in obtaining measurements with a time resolution that allows reliable 
kinetic analysis during large muscle mass exercise (e.g., cycling or running) has led to a 
predominant use of knee-extensor or forearm exercise with measurements of blood flow made by 
Doppler ultrasound (Shoemaker et al., 1996b; Shoemaker et al., 1997; Hughson et al., 1996; 
MacDonald et al., 1998; Fukuba et al., 2004; Radegran & Saltin, 1998). These investigations 
have shown that the Q
.
m response is biphasic with an initial fast phase determined by the 
combined effects of muscle contraction (muscle pump) (Sheriff & Hakeman, 2001) and possibly 
rapid vasodilation (Tschakovsky et al., 2004) followed by a second slower phase that appears to 
match O2 delivery and utilization (Shoemaker & Hughson, 1999). 
Several studies have addressed the relationship between Q
.
m and muscle V
.
O2 (V
.
O2m) 
kinetic response following the onset of exercise (Hughson et al., 1996; MacDonald et al., 1998; 
Grassi et al., 1996; Grassi et al., 1998; Grassi et al., 2000; Behnke et al., 2002a). Although 
Grassi et al. (1996) and Koga et al. (2005) demonstrated a similar time course for V
.
O2 and Q
.
m 
during moderate exercise, other human (Hughson et al., 1996; MacDonald et al., 1998) and 
animal studies (Grassi et al., 1998; Grassi et al., 2002; Behnke et al., 2002a) have shown that Q
.
m 
reaches a steady state level sooner than V
.
O2m (i.e, 5-10 s faster time constant). However, it is 
possible that the adjustment of Q
.
m in the microcirculation of active skeletal muscles may differ 
from that measured in larger conduit arteries (Laughlin & Korzick, 2001). To date, for technical 
and ethical reasons, assessing the kinetics of muscle capillary blood flow (Q
.
cap) in humans has 
been problematic. Resolution of this discrepancy in Q
.
m kinetics relative to those of V
.
O2m is 
crucial to advancing our understanding of the mechanisms which govern the control of both Q
.
m 
and V
.
O2m in health and disease. 
Near-infrared spectroscopy (NIRS) provides a noninvasive measure of muscle 
oxygenation (or O2 extraction) in the microcirculation. Although distinction between hemoglobin 
and myoglobin with regard to absorption of the near-infrared light cannot be made, the 
deoxygenated hemoglobin/myoglobin (deoxy-Hb/Mb) signal obtained by NIRS has been used as 
an index of local O2 extraction reflecting the V
.
O2m to Q
.
m ratio in the capillaries (Grassi et al.,  
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2003; DeLorey et al., 2003). The time course of deoxy-Hb/Mb following the onset of exercise 
resembles qualitatively and quantitatively the arteriovenous O2 difference (CaO2 – CvO2) 
observed in separate investigations (Grassi et al., 1996; Grassi et al., 1998; Grassi et al., 2000). 
Although these studies have not directly compared the kinetics of deoxy-Hb/Mb and (CaO2 – 
CvO2), collectively these observations suggest that the contribution of myoglobin to the NIRS 
signal does not distort the similarity between deoxy-Hb/Mb and (CaO2 – CvO2) kinetics. In fact, 
inferences about Q
.
m kinetics have been made based on the deoxy-Hb/Mb profile following the 
onset of exercise (Grassi et al., 2003; DeLorey et al., 2003; DeLorey et al., 2004b). 
Based on the above review, we propose that the kinetics of Q
.
cap could be estimated 
noninvasively by solving the Fick equation for blood flow (Q
.
cap = V
.
O2m/[ CaO2 – CvO2]), using 
the primary component of V
.
O2p and deoxy-hemoglobin ([HHb]) kinetics as surrogates of V
.
O2m 
and (CaO2 – CvO2) kinetics, respectively. Results from computer simulations suggest that the 
amplitude of the V
.
O2m and (CaO2 – CvO2) responses have little influence on the calculated Q
.
m 
kinetics (Chapter 2). Thus, assuming that the relative contributions of arterial and venous blood 
to the [HHb] signal remain constant, so that the proportionality of [HHb](t) to (CaO2 – CvO2)(t) 
also remains relatively constant, the temporal (kinetic) characteristics of Q
.
cap should be 
preserved. Therefore, the aims of the present study were to estimate the kinetics of Q
.
cap from the 
time course of V
.
O2p (primary component) and [HHb] following the onset of exercise and 
compare the overall kinetics of the estimated Q
.
cap with the estimated V
.
O2m kinetics. As the 
preponderance of studies investigating the temporal association between Q
.
m and V
.
O2m have 
shown that blood flow adjusted at a faster rate than O2 uptake (Hughson et al., 1996; MacDonald 
et al., 1998; Grassi et al., 1998; Behnke et al., 2002a), we hypothesized that the estimated Q
.
cap 
kinetics would also be faster than the V
.
O2m kinetics. 
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Methods 
 
Subjects: Nine healthy subjects (7 men, 2 women) with mean ± S.D. age 24.7 ± 6.3 years, 
body weight 67.9 ± 12.2 kg and height 175.4 ± 13.1 cm participated in this study. After 
explanation of  all procedures and possible risks and benefits of participation, each subject 
signed an informed consent form. The experimental protocol was approved by the Institutional 
Review Board for Research Involving Human Subjects at Kansas State University. 
 
Protocol: Subjects performed the exercise protocol on three separate days within a period 
of 2 wks, and were instructed to avoid strenuous exercise for at least 24 hr preceding each visit to 
the laboratory. On the first visit seat height and handlebar position on the cycle ergometer were 
recorded and these were reproduced on subsequent tests. 
The first visit was used to familiarize the subjects with testing procedures and to 
determine the peak oxygen uptake (V
.
O2peak), estimated lactate threshold (LT) and work rates for 
the constant work rate tests. All exercise tests were performed on an electronically-braked cycle 
ergometer (Corival 400, Lode, The Netherlands). The incremental exercise test involved 4 min of 
baseline cycling at 60 rpm followed by a progressive (ramp) increase in exercise intensity (15-30 
W·min
-1) to volitional exhaustion. V
.
O2peak was defined as the highest V
.
O2 achieved during the 
test averaged over a 15 s interval. The LT was estimated from gas exchange measurements using 
the V-slope method, ventilatory equivalents and end-tidal gas tensions (Beaver et al., 1986; 
Wasserman et al., 1973). The work rates calculated to elicit 90% of the LT VO2 (90% LT) and a 
V
.
O2 half way between the LT and V
.
O2peak (50% Δ = V
.
O2 LT + 0.5·[V
.
O2peak - V
.
O2 LT]), were 
determined. Over the next two visits, the subjects performed a total of 4-6 bouts of constant work 
rate exercise at 90% LT (6 min each) interspersed by 6 min at 20W, and 2 bouts at 50% Δ (8 min 
duration). The first bout was preceded by 4 min of baseline pedaling at 20W. Pulmonary V
.
O2 
and muscle oxygenation were measured continuously in all subjects and transitions. 
Pulmonary gas exchange (V
.
O2 and V
.
CO2) and minute expired ventilation (V
.
E) were 
measured breath-by-breath by an “open-circuit” method (CardiO2, Medical Graphics Corp., St. 
Paul, MN). Before each exercise test the volume signal was calibrated by pumping a 3-liter 
syringe at flow rates spanning the range expected during the exercise studies, while the O2 and 
CO2 analyzers were calibrated with gases of known concentration. Heart rate was recorded from 
the electrocardiogram using a modified lead I configuration and stored in the breath-by-breath 
file.   
Muscle oxygenation was evaluated by a frequency-domain multi-distance (FDMD) near-
infrared spectroscopy system (OxiplexTS, ISS, Champaign, IL). The principles of operation and  
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algorithms utilized by the equipment have been described in detail elsewhere (Gratton et al., 
1997). In this study we used a single channel consisting of eight laser diodes operating at two 
wavelengths (690 and 830 nm, four at each wavelength) and a photomultiplier tube (PMT). The 
laser diodes and PMT are connected to a lightweight plastic probe by optical fibers consisting of 
two parallel rows of emitter fibers and one detector fiber bundle comprising source-detector 
separations of 2.0, 2.5, 3.0 and 3.5 cm for both wavelengths. The frequency modulation of laser 
intensity was 110 MHz and the heterodyne detection was performed at a 5 KHz cross-correlation 
frequency. The output frequency was selected as 31.25 Hz. The probe was positioned 
longitudinally on the belly of the vastus lateralis muscle ~15 cm above the patella. To minimize 
motion artifacts and contamination of the signal by ambient light, the margins of the probe were 
bound to the thigh with a skin cement (Skin-Bond, Smith & Nephew, Largo, FL) after carefully 
shaving and drying the area, and secured with Velcro straps around the thigh. The probe position 
was marked to check for any sliding and for accurate repositioning on subsequent test days. No 
movement (sliding) was observed in any exercise test. The near-infrared spectrometer was 
calibrated on each test day after a warm-up period of at least 30 min. The calibration was done 
with the optical probe placed on a calibration block (phantom) with absorption and reduced 
scattering coefficients previously measured, and correction factors were determined and 
automatically implemented by the equipment’s software for the calculation of the absorption 
coefficient (μA) and reduced scattering coefficient (μ’s) for each wavelength during the data 
collection (Hueber et al., 2001). 
The FDMD method provides continuous measurement of absolute concentration of 
oxyhemoglobin ([HbO2]), deoxyhemoglobin ([HHb]) (expressed in μM) and μ’s (1/cm). The 
[HHb] reported in the present study was calculated incorporating the continuous measurement of 
μ’s made throughout the exercise test, i.e., without assuming a constant value for scattering. 
 
Kinetics Analysis: The breath-by-breath V
.
O2 and NIRS-oxygenation data were converted 
to second-by-second values. For each subject, the V
.
O2p and NIRS-oxygenation were time-
aligned to the start of exercise and ensemble-averaged to generate a single data set for each 
variable, at each exercise intensity, to improve the signal-to-noise ratio and confidence of fitting 
procedures. The kinetics of V
.
O2p, [HHb] and Q
.
cap (see below) were determined by nonlinear 
regression using a least squares technique (Marquadt-Levenberg, SigmaPlot 2001, Jandel 
Scientific). The model used for fitting the [HHb] response consisted of a single-exponential with 
a time delay (primary component of Eq. 1) or, a two-exponential term (primary and slow 
component of Eq. 1) when an additional “slow component” was observed 
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 [HHb](t) = [HHb](b) + AP·(1-e
- (t-TDp)/τp) (Primary component)      (1) 
   +   A S·(1-e
- (t-TDs)/τs)     (Slow component)  
 
The V
.
O2p response was fitted by conventional equations (Eq. 2) with two- (Phases 1-2) 
and three- (Phases 1-3) exponential terms for exercise below and above the LT, respectively 
 
V
.
O2 (t) = V
.
O2 (b) + AI·(1-e
- (t-TDi)/τi) (Phase  1)  (Initial component) 
  +   A P·(1-e
- (t-TDp)/τp) (Phase  2)  (Primary component)    (2) 
  +   A S·(1-e
- (t-TDs)/τs) (Phase  3)  (Slow component)    
 
where in Equations (1) and (2) the subscript b refers to baseline unloaded cycling; AI, AP and AS 
are the amplitudes; TDI, TDP and TDS are the time delays; and τI, τP and τS are the time constants 
of the exponential responses of interest for each variable. The initial (cardiodynamic) component 
of V
.
O2p was described up to TDP and the amplitude of the response at TDP (A’I) calculated as 
A’I = AI·(1 - e
-TDp/τi). The relevant amplitude of the primary component was calculated as A’P = 
A’I + AP. The 95% confidence limits for τp of V
.
O2 kinetics were on average τp ± 17 % (moderate 
exercise) and τp ± 35 % (heavy exercise).  
 
Muscle Capillary Blood Flow: The design used to investigate the kinetics of muscle 
capillary blood flow (Q
.
cap) in this study is conceptually similar to that applied in modeling 
studies (Barstow et al., 1990) and, more recently, in rat muscle preparations (Behnke et al., 
2002a). The Q
.
cap response to exercise was derived from the kinetics of V
.
O2p and [HHb]. The 
kinetics of the primary component of V
.
O2p during constant work rate exercise has been shown to 
approximate the muscle V
.
O2 (V
.
O2m) kinetics (Barstow & Mole, 1987; Barstow et al., 1990; 
Grassi et al., 1996; Rossiter et al., 1999), whereas [HHb] measured by NIRS is thought to be a 
function of the muscle oxygen uptake-to-blood flow ratio (V
.
O2m/Q
.
m) (Grassi et al., 2003; 
DeLorey et al., 2004b). The [HHb] signal has been shown to be less sensitive than [HbO2] to 
changes in blood volume under the field of interrogation, thus better representing the muscle 
oxygenation status during steady- and nonsteady-state situations (Ferrari et al., 1997; Grassi et 
al., 2003). Hence, assuming that arterial oxygen saturation did not change appreciably during 
moderate and heavy exercise in the present subjects, the [HHb] response was considered to be 
proportional to oxygen extraction (CaO2 – CvO2). Therefore, by rearranging the Fick equation, 
the temporal characteristic of Q
.
cap could be estimated from the ratio of V
.
O2m to [HHb], 
specifically,  
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In this circumstance, the amplitude of Q
.
cap is quantitatively uncertain because the precise 
proportional contribution of arterial and venous blood to the [HHb] signal are unknown for 
skeletal muscle. However, if this distribution remains constant from baseline to exercise in a 
given subject, the temporal (kinetic) characteristic of [HHb], and thus Q
.
cap, should be preserved. 
Consistent with this, the results from computer simulations have shown that the amplitude of       
V
.
O2 and (CaO2 – CvO2) responses have little influence on the calculated blood flow kinetics (see 
Chapter 1). The V
.
O2m kinetics were estimated using the kinetic parameters of V
.
O2p obtained 
from the curve fitting, i.e., by assuming that V
.
O2m rose exponentially at time zero with the time 
constant and amplitude determined for the primary component of the V
.
O2p response (e.g., Fig. 
3.1). The resulting estimated V
.
O2m kinetics was used to estimate the Q
.
cap kinetics (see Figs. 3.2-
3.3). The time course of Q
.
cap was analyzed with exponential equations as described above (Eq. 
2), where Q
.
cap is substituted for V
.
O2. At present we do not know if simple exponential equations 
provide the best mathematical description of the Q
.
cap response; however, we used methods 
similar to those previously employed to investigate the kinetics of muscle blood flow (Hughson 
et al., 1996; MacDonald et al., 1998; Radegran & Saltin, 1998; Shoemaker et al., 1996b). The 
mean response time (MRT) for Q
.
cap, which approximates the time to reach 63% of the response, 
was calculated as                                                                                                   
  
(4) 
 
where the parameters are from Eq. 2 and subsequent text. 
 
Statistical analysis: To determine significant differences between two means, a two-
tailed Student’s paired t-test was performed. A repeated-measures analysis of variance was 
performed to compare more than two means and the Tukey-Kramer’s post hoc test was used for 
pairwise comparisons. The relationship between two variables was analyzed by the Pearson’s 
product-moment correlation. Significance was accepted when P < 0.05. All tests were conducted 
using a commercial statistical software (NCSS 2000, NCSS Statistical Software, Kaysville, UT). 
Values were reported as mean ± S.D., unless otherwise specified.  
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Results 
 
The subjects’ V
.
O2 peak was 48.8 ± 7.0 ml·kg
-1·min
-1 and the estimated LT occurred at 56.3 
± 8.5 % V
.
O2peak. The work rates for the constant work rate tests were 115.0 ± 35.6 W (90% LT) 
and 205.7 ± 55.7 W (50% Δ).  
Preliminary analysis showed no main effect for the order of the moderate exercise bout 
averaged for visits 2 and 3 on Q
.
cap kinetics (MRT Q
.
cap = 25.9 ± 6.4 s, 25.1 ± 6.9 s and 25.6 ± 7.2 
s for bouts 1, 2 and 3 respectively; P = 0.73). Therefore, Q
.
cap kinetics during exercise at 90% LT 
was estimated based on [HHb] (and V
.
O2p) response from the 4-6 transitions ensemble-averaged 
to yield a single data set for each subject. 
The estimated V
.
O2m, [HHb] and estimated Q
.
cap response of a representative subject are 
shown in Fig. 3.2 (90% LT) and 3.3 (50% Δ), while Fig. 3.4 depicts the best regression fit 
through the Q
.
cap presented in Figs. 3.1-3.2. The kinetic parameters of Q
.
cap and [HHb] during 
moderate and heavy intensity exercise are presented in Table 1. As previously shown (Grassi et 
al., 2003), the TDI of [HHb] for heavy exercise was shorter than for moderate exercise (P < 
0.001) while no significant difference was observed for τI of [HHb].  
The results of the overall kinetics of V
.
O2, [HHb] and Q
.
cap are shown in Fig. 3.5. The 
MRT of [HHb] (TDP + τP) was significantly faster than Q
.
cap and V
.
O2 kinetics for moderate and 
heavy exercise (Fig. 3.5). However, the overall kinetics of Q
.
cap was similar to the estimated V
.
O2 
kinetics for both exercise intensities, i.e., MRT-Q
.
cap was not significantly different from τPV
.
O2p 
(Fig. 3.5). No exercise intensity effect was observed for either the MRT-Q
.
cap or τPV
.
O2p. Finally, 
there were significant correlations between MRT-Q
.
cap and the estimated τV
.
O2m (τPV
.
O2p) for 
moderate (r = 0.99; P < 0.001) and heavy exercise (r = 0.99; P < 0.001) (Fig. 3.6). 
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Discussion 
 
In the present study we sought to estimate the kinetics of muscle capillary blood flow, 
noninvasively, from the kinetics of pulmonary V
.
O2 and deoxy-hemoglobin, and to test the 
hypothesis that the resulting Q
.
cap kinetics were faster than muscle V
.
O2 kinetics. The main novel 
finding was that the estimated temporal profile of muscle blood flow in the microcirculation was 
tightly coupled to V
.
O2m kinetics. To the best of our knowledge this is the first study to 
noninvasively estimate, in humans, the time course of on-transient muscle blood flow in the 
microcirculation. Although the [HHb] signal from NIRS has been used to investigate the balance 
between blood flow and O2 uptake in the microcirculation under various experimental conditions 
(DeLorey et al., 2003; DeLorey et al., 2004b; Grassi et al., 2003), the kinetics of Q
.
cap itself have 
not previously been estimated as in the present study.  
 
Validity of Assumptions:  Two primary assumptions were made in order to estimate the 
temporal profile of Q
.
cap from the Fick principle. These involved the use of pulmonary V
.
O2 
(primary component) and [HHb] kinetics as surrogates of V
.
O2m and O2 extraction kinetics, 
respectively. Therefore the validity of these assumptions should be addressed before discussing 
the Q
.
cap profile observed herein. 
 
Pulmonary V
.
O2 as muscle V
.
O2:  The V
.
O2m was determined based on the kinetics of the 
primary component of V
.
O2p. The  V
.
O2p on-transient is characterized by two (moderate intensity) 
or three phases (heavy intensity) (Whipp et al., 1982), where the initial component has a 
cardiodynamic origin (“cardiodynamic hyperpnea”) (Whipp et al., 1982). The time course of the 
primary component of V
.
O2p has generally been shown or predicted to closely reflect (within 
10%) the V
.
O2m response (Barstow & Mole, 1987; Barstow et al., 1990; Grassi et al., 1996; 
Rossiter et al., 1999). Grassi et al. (1996) directly measured leg V
.
O2 and pulmonary V
.
O2 during 
cycling exercise and found that kinetics of the primary component of V
.
O2p were similar to, and 
consequently a good approximation of, the V
.
O2 leg kinetics. In a different modality (knee-
extension exercise), it has been demonstrated that phosphocreatine (PCr) breakdown (from 
31P-
NMR) followed a similar dynamic profile to that of the primary component of V
.
O2p during 
moderate intensity (below LT) exercise (Rossiter et al., 1999). Regarding the heavy exercise 
intensity domain (50% Δ, present study), approximately 86% of the pulmonary V
.
O2 slow 
component comes from the exercising legs (Poole et al., 1991). Therefore, based on 
experimental and theoretical studies (Barstow et al., 1990), it is reasonable to assume that the  
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primary and slow component of V
.
O2p approximates the time course of the muscle V
.
O2 response 
during moderate and heavy exercise.  
 
Deoxy-hemoglobin as arteriovenous oxygen difference:  Hemoglobin and myoglobin 
have similar absorption spectra that at present cannot be distinguished by near-infrared 
spectroscopy devices incorporating 2-4 wavelengths. There is ongoing controversy as to what 
extent the NIRS signal contains qualitatively significant information from Mb (Tran et al., 1999; 
Mancini et al., 1994; Seiyama et al., 1988). It has been generally accepted that the NIRS signal 
evolves predominantly from changes in oxy- or deoxy-Hb (McCully & Hamaoka, 2000); 
however, for its relevance to the present study this issue deserves further consideration.  
In rat thigh muscles perfused with perfluorocarbon to eliminate the NIRS signal arising 
from Hb, an interference from Mb of less than 10% was observed (Seiyama et al., 1988). These 
results were confirmed in human muscle by use of 
1H-NMR (Mancini et al., 1994). In contrast, 
Tran et al. (1999), also using 
1H-NMR, showed that in the human gastrocnemius the deoxy-Mb 
kinetics matched the NIRS oxygenation profile during cuff occlusion suggesting that the latter 
signal originated from Mb. It is noteworthy that the 
1H-NMR studies (Mancini et al., 1994; Tran 
et al., 1999) analyzed the tissue oxygen saturation (% StO2 = [HbO2]/Total[Hb]), while recent 
studies (Grassi et al., 2003; DeLorey et al., 2003) have emphasized the use of [HHb] as an index 
of O2 extraction (see below). The deoxy-Mb signal from the quadriceps muscle did not change 
from 50-60% to 100% WRmax (Richardson et al., 1995) whereas [HHb] continued to 
demonstrate a WR-dependency above 50-65% V
.
O2max (Grassi et al., 1999). Collectively, these 
observations suggest that NIRS light absorption in the quadriceps muscle is mainly associated 
with hemoglobin during exercise.       
The NIRS output has often been used to describe a global tissue O2 saturation (% StO2) 
and comparisons with direct measurements of venous O2 saturation during exercise have been 
made (MacDonald et al., 1999; Costes et al., 1996). There are two shortcomings to these studies 
that are relevant to the present one. First, as discussed by DeLorey et al. (2003) femoral venous 
oxygen saturation includes blood flow through both active and inactive muscles, whereas the 
StO2 was obtained from the m. vastus lateralis (active) only. To this point, Wilson et al. (1989) 
found good agreement between StO2 from NIRS of the contracting dog gracilis muscle and direct 
measurements of the isolated venous effluent O2 saturation from the same muscle. Second, 
changes in blood volume under the area of tissue sampled by the probe (cf. Fig. 4 MacDonald et 
al., 1999) will affect the [HbO2] and StO2 signals, independent of any changes in O2 extraction. 
On the other hand, the [HHb] is insensitive to blood volume changes (Ferrari et al., 1997) and 
has been used to assess variations in muscle O2 extraction (DeLorey et al., 2003; DeLorey et al.,  
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2004b). Indeed, Grassi et al. (2003) pointed out the striking similarity of [HHb] kinetics during 
moderate and heavy exercise with the time course of (CaO2 – CvO2). Specifically, in the dog 
gastrocnemius (Grassi et al., 2002), where venous outflow is isolated and, thus, errors due to 
multiple vessels draining the exercising muscle and muscle-to-sampling site transit delay are 
minimized, the O2 extraction kinetics (TD ~ 7.5 s and τ ~ 8 s, Grassi et al., 2002) were similar to 
those found for [HHb] in the present (Table 1) and other studies in exercising humans (DeLorey 
et al., 2003; Grassi et al., 2003). These findings provide a framework supporting the assumption 
of [HHb] as a noninvasive surrogate of (CaO2 – CvO2) to estimate the temporal profile of muscle 
capillary blood flow by the Fick principle. However, to our knowledge no study has directly 
compared the kinetics of [HHb] with those of (CaO2 – CvO2) for a single muscle and its entire 
venous outflow in exercising humans. Thus, this assumption must await direct validation.  
Since the Q
.
cap kinetics were estimated from indirect measures of V
.
O2m and (CaO2 – 
CvO2) kinetics, the estimated Q
.
cap kinetics will have some error when compared with the “true” 
Q
.
cap kinetics. Inasmuch as the error introduced by the assumption that [HHb](t) α (CaO2 – 
CvO2)(t) is not known, we cannot predict the extent of error that will be present in the estimated 
Q
.
cap kinetics. However, since the kinetics of V
.
O2p (primary component) reflects the V
.
O2m 
kinetics with a ± 10% error (see above), we might predict that the estimated Q
.
cap kinetics will 
represent the true Q
.
cap kinetics within ≥10% (or ≥ 2.5 s for the MRT-Q
.
cap observed herein). 
Nevertheless, based on the relationship between Q
.
m vs. V
.
O2m kinetics resulting from computer 
simulations of V
.
O2m and (CaO2 – CvO2) response to exercise (Chapter 2), and the estimated 
MRT-Q
.
cap vs. τPV
.
O2p (Fig. 3.6), it appears that the error due to the assumptions made are not 
much greater than 10%. 
 
Kinetics of muscle blood flow:  The muscle hemodynamic response following the onset 
of moderate exercise is characterized by two phases (for review see Shoemaker & Hughson, 
1999). In the present investigation the estimated muscle Q
.
cap response was also better described 
by a two-exponential model (three-exponential for heavy exercise) with the initial phase (phase 
1) lasting ~15-20 sec. These results are in concert with the kinetics of bulk blood flow 
determined in larger human vessels (Shoemaker et al., 1997; MacDonald et al., 1998) and those 
of red blood cells (RBC) in capillaries of contracting rat spinotrapezius muscle (Kindig et al., 
2002b). 
The rapid phase 1 response of Q
.
m is thought to be due to a mechanical effect of muscle 
contraction (i.e., muscle-pump) and possibly rapid vasodilation (Tschakovsky & Sheriff, 2004). 
Pharmacological interventions (Wunsch et al., 2000) and theoretical predictions (Kindig et al., 
2002b) suggest a lack of vasodilation during phase 1; however, recent studies have indirectly  
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pointed to the presence of a rapid vasodilation sufficient to elevate blood flow in conduit arteries 
(Tschakovsky et al., 2004; Hamann et al., 2004a). It is noteworthy that the kinetics of phase 1 
appear to be faster, with a greater contribution to the overall response, in rest-to-exercise 
transitions (Shoemaker et al., 1997; MacDonald et al., 1998; Kindig et al., 2002b) compared to 
exercise-to-exercise transitions (present study; Grassi et al., 1996). This response may reflect a 
greater muscle-pump effect as contraction frequency is an important determinant of the muscle-
pump (Sheriff & Hakeman, 2001). Our results, within the constraints of the assumptions made to 
estimate Q
.
cap kinetics (see above), suggest that a biphasic capillary blood flow response (Kindig 
et al., 2002b) is also present in the human muscle microcirculation. 
The second, slower phase of blood flow adjustment has been associated with feedback 
metabolic control, and several vasodilators have been proposed to mediate the response 
(Shoemaker & Hughson, 1999; Laughlin & Korzick, 2001; Hughson, 2003). The time constant 
of the primary component (or Phase 2) of Q
.
cap in the present study (~ 26 s, Table 3.1) was faster 
than those reported for the femoral artery (40 s, MacDonald et al., 1998 and 59 s, Koga et al., 
2005). The cause of this disparity is not clear, but its important to emphasize that a different 
exercise modality (knee-extension) was utilized in these studies compared to cycling in the 
present study. Also, in the current study Q
.
cap kinetics were estimated based on assumptions that 
would introduce some error in the estimated vs. “true” time constant of Q
.
cap (discussed above). 
However, it is unlikely that the potentially random error introduced by our assumptions would 
account for the ~ 14-25 s systematic difference with these previous studies. The overall blood 
flow response estimated in the current study by the mean response time was slower than some 
(Hughson et al., 1996; MacDonald et al., 1998) but similar to other (Grassi et al., 1996; Koga et 
al., 2005) studies on larger human vessels, when the relationship between Q
.
m and V
.
O2m kinetics 
is considered (Figure 3.4A). In general, our results differ from those studies that investigated 
rest-to-exercise transitions (Hughson et al., 1996; MacDonald et al., 1998), but agree with results 
from studies using exercise-to-exercise protocols (Grassi et al., 1996; Koga et al., 2005). 
Therefore, the inconsistency of results could be related to differences in the phase 1 profile of Q
.
m 
and its relative contribution to the overall response (see above). 
For heavy exercise, comparison of MRT or τP of blood flow with previous investigations 
in humans is not straightforward because we chose to truncate the MRT so as to reflect the 
primary component of the response while others have included the blood flow increase 
associated with the V
.
O2 slow component (Radegran & Saltin, 1998; Bangsbo et al., 2000; 
Fukuba et al., 2004). The rationale for limiting the calculation of the heavy exercise MRT was 
that we were interested in determining the relationship between the primary components of the 
estimated Q
.
cap and V
.
O2m kinetics. Further, it is not clear if the time course of [HHb]  
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approximates the dynamics of (CaO2 – CvO2) during the slow component phase of V
.
O2 (Poole et 
al., 1991) which technically limited us from determining the MRT for the total response (primary 
and slow component). Based on the relationship presented in Figure 4B, our results for Q
.
cap 
kinetics are in agreement with the primary component of Q
.
m kinetics in the dog gastrocnemius 
muscle preparation contracting at V
.
O2peak (Grassi et al., 2000). 
 
Dynamic coupling of Q
.
m to V
.
O2m:  In the present study the estimated temporal profile of 
Q
.
cap was directly related to the V
.
O2m kinetics. As seen in Fig. 3.4, the association between blood 
flow and V
.
O2 kinetics has been demonstrated by a number of investigators (MacDonald et al., 
1998; Hughson et al., 1996; Grassi et al., 1996; Grassi et al., 2002; Koga et al., 2005). Some 
studies have shown that the time constants for adjustment of blood flow were 5-10 s faster than 
those of V
.
O2 during moderate exercise (Hughson et al., 1996; MacDonald et al., 1998; Grassi et 
al., 2002), while others have found similar kinetics for Q
.
m and V
.
O2 (Grassi et al., 1996; Koga et 
al., 2005) for moderate exercise. Our results are in agreement with the latter studies, and suggest 
that in the human muscle microcirculation, under the experimental conditions and assumptions 
of this investigation, the dynamic adjustment of blood flow is intimately coupled to the time 
course of V
.
O2m. As noted above, rest-to-exercise transitions were associated with overall Q
.
m 
kinetics faster than V
.
O2m kinetics (Hughson et al., 1996; MacDonald et al., 1998) while 
exercise-to-exercise transitions (“unloaded” to exercise) demonstrated Q
.
m kinetics similar to      
V
.
O2 kinetics (Grassi et al., 1996; Koga et al., 2005). This could be the result of differences in the 
initial phase of the Q
.
m response, possibly due to a greater muscle-pump effect during rest-to-
exercise transitions (see above). Collectively, this raises an interesting question: Does the 
muscle-pump induced increase in blood flow alter the coupling between Q
.
m and V
.
O2m during 
rest-to-exercise transitions? The mechanisms underlying the close association between Q
.
m and  
V
.
O2m kinetics are not presently clear because studies of muscle blood flow in the 
microcirculation during the transitional phase of exercise are scarce. Pharmacological blockade 
of vasodilator pathways did not change the overall time course of bulk blood flow adjustment 
(e.g., Shoemaker et al., 1997), but the possibility of different effects on the microcirculation 
cannot be excluded (Laughlin & Korzick, 2001). 
In this context, it has been suggested that the time constant of phase 2 should be used to 
investigate the control of muscle blood flow because phase 1 may have a mechanical origin 
which increases blood flow indiscriminately to active and nonactive muscle fibers (Hughson, 
2003). In the current model we chose to evaluate the temporal association between the MRT for    
Q
.
cap and τP of V
.
O2p. As discussed above, τPV
.
O2p is a reasonable approximation of muscle V
.
O2 
kinetics, whilst the MRT was selected to reflect the overall kinetics of blood flow due to the  
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present uncertainty about the mechanism(s) of Q
.
cap phase 1. In fact, recent studies have indicated 
the presence of a rapid vasodilation that is related to muscle metabolism (Tschakovsky et al., 
2004). Therefore, based on current knowledge of the blood flow response to exercise, it is our 
contention that the mean response time gives a better representation of the overall temporal 
profile of blood flow. Using this analysis, the kinetics of Q
.
cap were found to be similar to VO2 
kinetics during moderate and heavy exercise. From these results alone, it is difficult to make 
inferences about the potential role of O2 delivery to determine the kinetics of V
.
O2m during 
upright cycling exercise (present study). V
.
O2m kinetics reflects the interaction between O2 
delivery and metabolic inertia (Tschakovsky & Hughson, 1999). If Q
.
cap (and presumably O2 
delivery) kinetics had been clearly faster than V
.
O2 kinetics it would suggest that O2 delivery was 
not the limiting factor to V
.
O2m kinetics. Conversely, if the kinetics of Q
.
cap were slower than O2 
uptake kinetics it might suggest an O2 delivery limitation to V
.
O2m kinetics. However, our results 
lie between these two extremes. It is important to note that similar kinetics for Q
.
cap and V
.
O2m 
does not necessarily mean that Q
.
cap (and by inference O2 delivery) limits V
.
O2m kinetics. To this 
point, augmented O2 delivery in the transitional phase of moderate exercise did not change 
significantly the kinetics of V
.
O2 (MacDonald et al., 1997; Grassi et al., 1998). In contrast, 
during heavy exercise, enhanced O2 delivery resulted in faster V
.
O2 kinetics in some [pump-
perfused muscle (Grassi et al., 2000); prior exercise (Tordi et al., 2003)], but not all studies 
(prior exercise, Wilkerson et al., 2004). In our study, estimated V
.
O2m and Q
.
cap kinetics were 
similar for both exercise intensities (Fig. 3.6). Therefore, it cannot be ascertained, from our data 
only, how O2 delivery and metabolic inertia interact to determine V
.
O2m kinetics (for further 
discussion on this topic see Tschakovsky & Hughson, 1999; Tordi et al., 2003; Wilkerson et al., 
2004). 
 
Methodological considerations:  The basic assumptions made to estimate the temporal 
profile of Q
.
cap were discussed in detail above. It is important to recognize, however, that possible 
subtle changes in the exponential characteristic of V
.
O2m response occurring in the transitional 
phase will be masked by the breath-by-breath noise of pulmonary V
.
O2, which prevents statistical 
justification of higher-order models, but has important physiological implications (Hughson et 
al., 2001); however, resolution of this limitation is not possible at present. In addition, we have 
assumed that V
.
O2m and (CaO2 – CvO2), estimated locally from NIRS, were proportionately 
distributed among the exercising muscles. However, the skeletal muscles recruited are not 
homogeneous, either with respect to their relative contribution to the work of cycling, or with 
regard to muscle fiber type, recruitment pattern and distribution of blood flow (Laughlin & 
Armstrong, 1982). At present, resolution of both the intra- and inter-muscular heterogeneity of   
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Q
.
/V
.
O2 during cycling is not possible and must await further advances in methods such as those 
recently reported (Mizuno et al., 2003).  
Two inherent limitations of NIRS are the small tissue volume sampled by the probe and 
the relatively shallow light penetration depth. In this study we used the m. vastus lateralis based 
on electromyography (EMG) activity, which indicates that the m. vastus lateralis provides a good 
representation of muscle recruitment during cycling (Li & Caldwell, 1998). Contribution from 
other muscles (by EMG) during heavy exercise may become important during the period 
corresponding to the slow component of V
.
O2p (Burnley et al., 2002), but this is expected to have 
minor effects on our results because we restricted our analysis to the primary component of       
V
.
O2p, [HHb] and estimated Q
.
cap. Regarding the light penetration depth, the predominance of 
type II fibers in superficial muscle areas (Lexell et al., 1983) could result in slower estimated     
Q
.
cap kinetics, if the lower endothelium-dependent vasodilator response of type II fibers 
demonstrated in animal muscles (Woodman et al., 2001) is observed in human muscles. The 
potential influence of fiber type regionalization on the NIRS estimated Q
.
cap kinetics must await 
further studies. Finally, we assumed that the relative contribution of arterioles, capillaries and 
venules to the [HHb] signal remained constant during the exercise period. This is a technical 
limitation of NIRS in general that cannot be solved at present. However, based on the similarity 
between the temporal profile of [HHb] observed in the present study and recently reported by 
others (Grassi et al., 2003; DeLorey et al., 2003), and the dynamics of O2 extraction measured in 
other studies (Grassi et al., 1996; Grassi et al., 1998; Grassi et al., 2000) a possible shift in the 
vessels contributing to the [HHb] signal would not invalidate our assumption. 
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Conclusions 
 
In summary, this study introduced a new method to noninvasively estimate the time 
course of muscle capillary blood flow (Q
.
cap) from the kinetics of pulmonary V
.
O2 and deoxy-
hemoglobin ([HHb]) from NIRS. The resulting estimated Q
.
cap kinetics were similar to V
.
O2p 
(phase 2) kinetics indicating that in the microcirculation muscle blood flow is tightly coupled to 
muscle oxygen uptake following the onset of exercise. Moreover, the temporal profile of the 
estimated Q
.
cap response suggests that in human muscles the kinetics of capillary blood flow is 
biphasic, as previously shown in the rat muscle (Kindig et al., 2002b). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
47
 
Table 3.1. Kinetic parameters of O2 uptake, capillary blood flow and [HHb]. 
Parameter Q
.
cap [HHb] 
  Moderate Heavy  Moderate Heavy 
Baseline   33.8 ± 10.6  38.4 ± 11.8 *  23.4 ± 8.8  21.4 ± 8.4 * 
A’I  15.7 ± 6.6  18.8 ± 7.5 *     
τI (s)  6.7 ± 2.7  3.3 ± 1.6 *     
AP  14.4 ± 9.1  30.2 ± 13.9 *     
A’P   30.1 ± 13.5  49.0 ± 18.7 *  6.06 ± 4.57  11.0 ± 7.5 * 
TDP (s)  18.9 ± 4.6  13.6 ± 4.8 *  8.5 ± 1.8  5.1 ± 1.5 * 
τP (s)  28.3 ± 5.8  25.7 ± 5.0  9.3 ± 3.1  8.6 ± 1.9 
 
Values are mean ± SD. A, amplitude. TD, time delay and τ, time constant of each 
component. I, initial component; P, primary component. A’p, amplitude of primary component of 
response (A’I + AP, for Q
.
cap). * Significantly different from moderate exercise (P < 0.05). 
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Figure 3.1. Schematic illustrating the estimation of muscle O2 uptake from pulmonary O2 
uptake. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Schematic illustrating the procedure used to estimate, from the time constant 
(τ) and amplitude of the primary component (A’1) of the pulmonary V
.
O2 (V
.
O2p) response (A), 
and the kinetics of muscle V
.
O2 (V
.
O2m) (B). A) Dashed line, best regression fit through the V
.
O2p 
corresponding to the cardiodynamic phase; Solid line, best regression fit through the primary 
component of V
.
O2p response extended back to the baseline value, to illustrate how V
.
O2m kinetics 
were estimated from the V
.
O2p response. V
.
O2m kinetics shown in (B) (Solid line) depicts the solid 
line shown in (A), but with V
.
O2m rising exponentially from time zero. The resulting V
.
O2m 
kinetics (as shown in B), were then used to estimate the Q
.
cap kinetics (Figs. 3.2-3.3). 
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Figure 3.2. Representative data for moderate exercise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. Representative data for constant moderate work rate exercise (90% LT) of 
one subject. A) muscle V
.
O2 (V
.
O2m, L·min
-1) estimated from the kinetics parameters of 
pulmonary V
.
O2 (as shown in Fig. 1); τ, time constant of V
.
O2p (primary component, Eq. 2), B) 
deoxy-hemoglobin concentration ([HHb], μM); MRT, mean response time (time delay plus time 
constant) and C) estimated temporal profile of muscle capillary blood flow (Q
.
cap) obtained as     
V
.
O2m divided by [HHb]; MRT was determined as in Eq. 5. The amplitude observed in C does 
not reflect the ‘true’ amplitude of blood flow; however, the kinetics should be robust (see text). 
Note that in this subject (and also in two other subjects) [HHb] temporarily decreased in the first 
seconds of exercise, indicating that Q
.
cap initially (first 5-10 s) increased faster than V
.
O2m. Other 
possible causes of this early decrease in [HHb] has been discussed in detail by DeLorey et al. 
(2003) and Grassi et al. (2003).   
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Figure 3.3. Representative data for heavy exercise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Representative data for heavy exercise (50% Δ) from the subject presented in 
Fig. 3.2. τP, time constant of primary component. MRTP, mean response time of primary 
component. See Fig. 3.2 for abbreviations and further details on panels A, B and C.  
 
 
 
 
 
 
  
 
 
51
Figure 3.4. Estimated muscle capillary blood flow (moderate and heavy exercise). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4. Estimated muscle capillary blood flow (Q
.
cap; open circles) for moderate 
exercise (A, from Fig. 3.2C) and heavy exercise (B, from Fig. 3.3C). Solid line represents the 
best fit using Eq. 2. Note the presence of an early ‘phase 1’ for both moderate (A) and heavy 
exercise (B). Note that in B the last 120 s of data (360-480 s) are not shown so as to facilitate 
visualization of the primary component of the Q
.
cap response. 
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Figure 3.5. Overall kinetics of deoxy-hemoglobin, O2 uptake and estimated capillary blood 
flow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Overall kinetics (mean response time, MRT) of deoxy-hemoglobin 
concentration ([HHb]), pulmonary V
.
O2 and muscle capillary blood flow (Q
.
cap). For pulmonary  
V
.
O2 MRT represents the time constant of the primary component of the response (Eq. 2). The 
data are mean ± S.D. (Error bars). *Significantly different from τPV
.
O2 and MRT-Q
.
cap (P < 0.05). 
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Figure 3.6. Relationship between kinetics of blood flow and O2 uptake. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Relationship between mean response time of muscle capillary blood flow 
(MRT-Q
.
cap) and time constant of pulmonary V
.
O2 (τV
.
O2p; primary component) for moderate (A; 
r = 0.99, P < 0.001) and heavy exercise (B; r = 0.99, P < 0.001). Also shown are the means ± 
s.e.m. (symbol ± error bars) from previous studies investigating the relationship between muscle 
blood flow and muscle V
.
O2. In (A) and (B) solid line represents line of identity. A) closed 
circles, present study; open circle dotted, cycling (Grassi et al., 1996); open triangle down, knee-
extension (Koga et al., 2005); open square, dog gastrocnemius (Grassi et al., 1998); open 
triangle up, knee-extension (MacDonald et al., 1998); open circle, forearm exercise (Hughson et 
al., 1996); open diamond, rat spinotrapezius (Behnke et al., 2002a). B) closed circles, present 
study; open circle, dog gastrocnemius (Grassi et al., 2000). Note that for the present study and 
the studies of MacDonald et al. (1998) and Koga et al. (2005), τV
.
O2 corresponds to the time  
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constant of primary component of pulmonary V
.
O2. For Hughson et al. (1996) the data shown 
represents the results of arm exercise below heart level. In Grassi et al. (1998), τV
.
O2 and MRT-
Q
.
 were calculated from the reported t50% and for Grassi et al. (2000), they correspond to the 
reported τ + TD of V
.
O2 and Q
.
m, respectively.  
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CHAPTER 4 - Effects of altered nitric oxide availability on rat 
muscle microvascular oxygenation during contractions 
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Summary 
 
The present study was developed to explore the role of nitric oxide (NO) in controlling 
microvascular O2 pressure (PO2mv) at rest and during contractions (1 Hz).  We hypothesized that 
at the onset of contractions sodium nitroprusside (SNP) would raise PO2mv and slow the kinetics 
of PO2mv change whereas L-nitro arginine methyl ester (L-NAME) would decrease PO2mv and 
speed its kinetics.  The spinotrapezius muscle of female Sprague-Dawley rats (n = 7, body mass 
= 298 ± 10 g) was superfused with SNP (300 μM) and L-NAME (1.5 mM) and measured PO2mv 
(phosphorescence quenching). SNP decreased mean arterial pressure (92 ± 5 mmHg) below that 
of control (CON, 124 ± 4 mmHg) and L-NAME (120 ± 4 mmHg) conditions.  SNP did not raise 
PO2mv at rest but it did elevate the PO2mv-to-MAP ratio (50% increase, P < 0.05) and slow the 
kinetics by lengthening the time delay (TD, 14.0 ± 5.0 s) and time constant (τ, 24.0 ± 10.0 s) of 
the response compared with CON (TD, 8.4 ± 3.3 s; τ, 16.0 ± 4.5 s, P < 0.05 vs. SNP).  L-NAME 
decreased PO2mv at rest and tended to speed τ (10.1 ± 3.8 s, P = 0.1), while TD (8.1 ± 1.0 s) was 
not significantly different.  L-NAME also caused PO2mv to fall transiently below steady-state 
contracting values.  These results indicate that NO availability can significantly affect PO2mv at 
rest and during contractions and suggests that PO2mv derangements in aging and chronic disease 
conditions may potentially result from impairments in NO availability. 
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Introduction 
 
To power oxidative phosphorylation and minimize reliance on finite energy sources 
during muscle contractions O2 must be transported from the lungs to the mitochondria.  The 
penultimate step in this pathway, which may be limiting during exercise, is at the capillary-
myocyte barrier (Wagner, 1996).  The O2 pressure (PO2) gradient, i.e. the PO2 difference 
between the capillary or microvascular blood and that in the intramyocyte space, is the exclusive 
driving force for O2 flux into the myocyte (Fick’s law of difusion).  Thus, if microvascular PO2 
(PO2mv) falls below that necessary to drive a given O2 flux, muscle O2 uptake (V
.
O2) will be 
compromised and a greater reliance will be placed upon substrate-level phosphorylation (e.g. 
creatine phosphate) and anaerobic glycolysis for ATP requirements (Hogan et al., 1992).   
Microvascular PO2 is determined by the matching of muscle O2 delivery (Q
.
O2) and V
.
O2, 
i.e., Q
.
O2/V
.
O2.  At the onset of muscle contractions, when V
.
O2 is rising at its fastest rate, Q
.
O2 
must rise in proportion to V
.
O2 in order to limit or constrain the fall of PO2mv which would 
compromise muscle oxidative function.  In healthy young muscles at the onset of contractions, 
PO2mv remains at or close to resting levels for 10-20 s (time delay, TD) before decreasing 
exponentially to a steady-state level that is determined by the muscle fiber type as well as the 
stimulation characteristics (Behnke et al., 2001; Behnke et al., 2002a; Behnke et al., 2003; 
McDonough et al., 2005).  This profile is thought to reflect a biphasic increase of Q
.
O2 that is 
superimposed upon a monoexponential V
.
O2 response (MacDonald et al., 1998; Shoemaker & 
Hughson, 1999; Behnke et al., 2001; Kindig et al., 2002b; Ferreira et al., 2005b; Koga et al., 
2005).  In marked contrast to this healthy response, aging (Behnke et al., 2005) and disease 
conditions such as chronic heart failure [CHF; (Diederich et al., 2002)] and diabetes (Behnke et 
al., 2002b) are characterized by a much faster fall of PO2mv following the onset of contractions.  
Moreover, in old individuals and these disease conditions PO2mv decreases transiently below its 
end-contraction value in contrast to the monoexponential PO2mv profile seen in young healthy 
muscles.  In this context, PO2mv may achieve very low levels either transiently or for the 
duration of the contractions bout.  In both instances the PO2mv, which constitutes the upstream 
pressure facilitating mitochondrial O2 delivery, is compromised and this is likely to contribute to 
the slowed V
.
O2 kinetics characteristic of these conditions (Meakins & Long, 1927; Riley et al., 
1994; Regensteiner et al., 1998; Hepple et al., 1999; Bell et al., 1999; Scheuermann et al., 2002). 
Amongst the numerous mechanisms that increase Q
.
O2 in the contracting muscle, the 
muscle pump, nitric oxide (NO), cyclooxygenase, endothelial-derived hyperpolarizing factor, 
and contraction-induced metabolites (including H
+, K
+ and CO2) as well as conducted 
vasodilation (Segal, 2000; Tschakovsky & Sheriff, 2004) have been considered important.  There  
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are likely to be interspecies variations in the relative importance of these mechanisms, however, 
NO-mediated vasodilation has been demonstrated to be crucial in sustaining the exercise 
hyperemia seen in running rats (Hirai et al., 1995) and the cardiac output in horses (Bailey et al., 
2000).  Moreover, aging (Taddei et al., 1995; Woodman et al., 2002; Tanabe et al., 2003), CHF 
(Drexler et al., 1992; Hirai et al., 1995; Varin et al., 1999), and diabetes (De Vriese et al., 2000; 
Bagi & Koller, 2003) are all associated with a downregulation of endothelial function and/or 
endothelial NO production.  In addition to its effects on Q
.
O2, NO has an important role in 
modulating mitochondrial oxidative phosphorylation (Brown, 2000).  Accordingly, blockade of 
nitric oxide synthase speeds the kinetics of V
.
O2 in humans (Jones et al., 2003; Jones et al., 
2004b) and horses (Kindig et al., 2001; Kindig et al., 2002a) but not in the dog gastrocnemius 
muscle (Grassi et al., 2005).   
Therefore, the purpose of the present investigation was to explore the role of NO on the 
Q
.
O2-to-V
.
O2 matching (as assessed from measurements of PO2mv) across the rest-to-contractions 
transition.  Specifically, we tested the hypothesis that at the onset of contractions: 1. increasing 
NO availability via sodium nitroprusside superfusion would elevate resting and contracting 
PO2mv and slow the dynamic fall of PO2mv.  2. L-NAME induced decrease of NO availability 
would reduce resting and contracting PO2mv and speed the dynamic fall of PO2mv.  We further 
hypothesized that L-NAME would induce a transient lowering of PO2mv below the steady-state 
value that would be qualitatively similar to that seen in conditions associated with reduced NO 
availability, e.g., aging, CHF and diabetes.  
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Methods 
 
Animals:  Seven female Sprague-Dawley rats (body mass 298 ± 10 g) were used in this 
investigation.  Rats were maintained on a 12:12-h light-dark cycle and received water and food 
ad libitum.  Upon completion of the study, each animal was euthanized with pentobarbital 
sodium.  All procedures described herein were approved by the Kansas State University 
Institutional Animal Care and Use Committee (IACUC). 
 
Surgical Preparation:  The animals were anaesthetized with pentobarbital sodium (50 mg 
kg
-1 I.P., to effect) and placed on a heating pad to maintain a constant body temperature (~38 °C) 
throughout the experimental protocol.  The left carotid artery was cannulated (Polyethylene-50, 
Intra-Medic tubing, Clay Adams, Sparks, MD, USA) for infusion of the phosphorescent probe 
palladium meso-tetra (4-carboxyphenyl) porphyrin dendrimer (R2; 15 mg/kg), monitoring of 
arterial blood pressure (Digi-Med BPA model 200, Louisville, KY, USA) and blood withdrawal.  
Arterial blood was sampled after completion of the experimental protocol to determine blood 
gas, pH, and plasma lactate (Nova Stat Profile M, Waltham, MA, USA), as well as systemic 
haematocrit (Adams Micro-Hematocrit reader, Clay Adams, Parsipanny, NJ, USA). 
The skin and overlying fascia of the mid-dorsal region of the rat was reflected back to 
expose the right spinotrapezius muscle.  The spinotrapezius is a postural muscle that originates 
on the lower thoracic and upper lumbar region closely associated with the vertebral column and 
inserts on the scapula.  The muscle and surrounding tissue were kept moist with a Krebs-
Henseleit bicarbonate-buffered solution (4.7 mM KCl, 2.0 mM CaCl2, 2.4 mM MgSO4, 131 mM 
NaCl, and 22 mM NaHCO3) equilibrated with 5 % CO2-95 % N2 at 38 °C and covered with 
Saran Wrap (Dow, Indianapolis, IN, USA) between stimulation periods.   
 
Muscle stimulations:  Electrical stimulation of the muscle was conducted (1 Hz; 4-6 V; 2 
ms pulse duration) to elicit twitch muscle contractions using a Grass S88 stimulator (Quincy, 
MA, USA) for 3 min.  These stimulation parameters have been shown to elicit an increase in 
blood flow of ~ 240% and increase in V
.
O2 of ~ 350% (Behnke et al., 2002a).  To elicit muscle 
contractions, stainless steel plate electrodes (2.5 mm diameter) were sutured to the rostral 
(cathode) and caudal region (anode) of the muscle using 6-0 sutures.  The sutures were necessary 
to avoid changes in electrode position upon superfusion of the muscle.   
 
Experimental Protocol:  Upon completion of the surgery, the phosphor R2 was infused 
via the arterial cannula approximately 15 min before the first stimulation period for measurement  
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of PO2mv (see below).  The spinotrapezius muscle was superfused with Krebs-Henseleit (CON), 
SNP (300 μM in Krebs-Henseleit) and L-NAME (1.5 mM in Krebs-Henseleit).  These 
concentrations were established based on preliminary experiments.  All solutions were 
maintained at ~38°C.  The dose of SNP was titrated to avoid a decrease in MAP below 60-70 
mmHg at any time.  Sodium nitroprusside displayed an effect on MAP of rapid onset, while L-
NAME did not affect MAP suggesting that a physiologically relevant leakage of L-NAME into 
the systemic circulation did not occur.  The order of treatment was SNP, CON and L-NAME.  
The SNP trial was always first to minimize the total procedure time and any potential transient 
vasoconstriction induced by suturing of electrodes to the muscle, while L-NAME was the last 
treatment due to its long half-life that prevented randomization of CON and L-NAME 
conditions.  Prior to stimulation the muscle was superfused for a total of 15-20 min with each 
solution (average flow rate 1-2 ml·min
-1).  A 10 min period was allowed between the end of 
muscle stimulation and start of superfusion with CON and L-NAME solutions.  After the end of 
the SNP trial the muscle was superfused with Krebs-Henseleit for 25-30 min (i.e., 10 min 
constantly flushing of the muscle to wash out SNP, plus 15-20 min to replicate the drug 
treatments).  It is noteworthy that preliminary experiments showed no order effect on any 
parameter of PO2mv kinetics (Eq. 1) when the muscles were allowed to recover for 25-30 min 
(Ferreira, Padilla, Williams, Hageman, Musch and Poole, unpublished findings).  The total 
procedure time (i.e. surgery and stimulation periods) did not exceed 4 hours.   
 
Microvascular PO2 measurements:  Microvascular PO2 (PO2mv) was measured using the 
phosphorescence quenching method.  As described previously (Behnke et al., 2001; Behnke et 
al., 2002a; Geer et al., 2002), the phosphorescence quenching technique used to determine 
PO2mv is based upon the Stern-Volmer relationship (Rumsey et al., 1988) which describes 
quantitatively the O2 dependence of the phosphorescent probe (i.e. R2).  As a non-toxic 
dendrimer (Lahiri et al., 1993), the R2 probe is bound to albumin at 38°C and pH 7.4, and is 
uniformly distributed in the plasma providing a signal corresponding to the volume-weighted O2 
pressure in the microvascular compartment [principally the PO2 within the capillary space, which 
volumetrically constitutes the major intramuscular vascular space (Poole et al., 1995)].  In 
addition to binding to albumin, R2 is negatively charged which helps facilitate restriction of the 
compound to the vascular space (Poole et al., 2004).  We used values for the quenching constant 
and lifetime of phosphorescence decay in the absence of O2 for R2 of 409 mmHg·s
-1 and 601 μs, 
respectively (Lo et al., 1997; Pawlowski & Wilson, 1992).  
Microvascular PO2 was determined using a Frequency Domain Phosphorometer (PMOD 
1000, Oxygen Enterprises Ltd, Philadelphia, PA, USA) at 2s intervals.  The common end of the  
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bifurcated light guide was placed 2-3 mm above the medial region of the spinotrapezius (i.e. 
superficial to the dorsal surface) with the excitation light focused on a ~2 mm diameter circle.  
Movement of the light guide (or animal) was avoided to monitor the same sampling site 
throughout the experiment.  On a few occasions, repositioning of the phosphorometer light guide 
was necessary in order to sample PO2mv from precisely the same location of the spinotrapezius 
muscle.  The phosphorometer employs a sinusoidal modulation of the excitation light (524 nm) 
at frequencies between 100 Hz and 20 kHz, which permits phosphorescence lifetime 
measurements from 10 μs to ~2.5 ms.  Ten scans (100 ms) were performed in the single 
frequency mode to acquire the resultant lifetime of the phosphorescence (700 nm) (Vinogradov 
et al., 2002).   
 
Curve-fitting of PO2mv dynamics:  The dynamics of PO2mv were described by nonlinear 
regression analysis using commercial software packages (SigmaPlot 7.01, Systat Software, CA, 
USA).  Goodness of fit was determined via three criteria: 1) the coefficient of determination (r
2), 
2) the sum of the squared residuals (i.e. χ
2), and 3) visual inspection.  The equation used to 
describe the kinetics of PO2mv was  
 
PO2mv(t) = PO2mv(baseline) - ∆PO2mv(primary) [1 - e
-(t-TD1)/τ1]      (primary component)     (1) 
                         + ∆PO2mv(secondary) [1 - e
-(t-TD2)/τ2] (secondary  component) 
 
where baseline corresponds to precontraction PO2mv, and ∆ is the amplitude of the PO2mv 
response.   The time constants are indicated as τ1 and τ2, and TD1 and TD2 are the independent 
time delays of the respective responses.  For monoexponential responses only the primary 
component was used to describe the data.  An equation including the primary and secondary 
components was used whenever we observed a consistent decrease in PO2mv below its end-
contraction value.  While we are not certain that the secondary component is exponential this 
fitting procedure has been successfully used in previous studies allowing an excellent description 
of the data (see above) to examine the overall kinetics of PO2mv (Behnke et al., 2002b; 
Diederich et al., 2002; Behnke et al., 2003; Behnke et al., 2005). The results from curve fitting 
were then used to calculate the nadir and end-stimulation PO2mv.   
 
Statistics:  Means were compared with one-way ANOVA, while the Student-Newman-
Keuls test was used for post-hoc analysis.  Statistical significance was accepted at P < 0.05.  All 
tests were conducted with commercially available software (SigmaStat 3.0, Systat Software, CA, 
USA).  Data are reported as mean ± SEM.  
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Results 
 
Arterial O2 saturation was 93 ± 1 %, systemic haematocrit 41.0 ± 0.77 %, arterial blood 
pH 7.45 ± 0.01 and plasma lactate 1.6 mmol·L
-1.  Mean arterial pressure (MAP) decreased 
significantly during superfusion with SNP (92 ± 5 mmHg), while MAP for Control (124 ± 4 
mmHg) and during the superfusion with L-NAME (120 ± 4 mmHg) were not significantly 
different. 
The PO2mv response was substantially different for Control, SNP and L-NAME both 
qualitatively (Figs. 4.1 and 4.2A) and quantitatively (Figs. 4.2B and 4.3).  Baseline PO2mv was 
significantly lower during L-NAME compared to Control and SNP (Fig. 4.3), while no 
significant difference was seen for SNP vs. Control.  However, when normalized for changes in 
MAP a significant difference was observed for both SNP and L-NAME compared to Control 
(Fig. 4.2B).  Specifically, before muscle stimulations the PO2mv-to-MAP ratio was 50% higher 
during SNP and 30% lower during L-NAME compared to Control, which demonstrates that a 
substantial drug effect was achieved.  At the end of stimulation PO2mv was significantly higher 
during SNP, while L-NAME decreased PO2mv significantly compared to Control (Fig. 4.3).  
The overall dynamics of PO2mv, represented by the MRT, were slower during SNP 
compared to Control (Fig. 4.3). Specifically, we observed a longer time delay (TD) during SNP 
vs. Control and a slower time constant (τ) of PO2mv (Fig. 4.3).  Thus, the MRT (TD + τ) was 
significantly longer for SNP vs. Control.  In contrast, L-NAME tended to speed the kinetics of 
PO2mv compared to Control (similar TD with a tendency for significantly faster τ; P = 0.1) and 
led to a transient PO2mv decrease below the final contracting steady-state PO2mv (Figs. 4.1-4.2).  
This response was characterized by a better fit of the L-NAME response with a two-component 
model as opposed to the one-component model in all animals studied.  In marked contrast, the 
best fit for the Control response of only one animal (out of seven) was achieved with a two-
component model.  For unknown reasons one animal demonstrated an apparently linear increase 
in PO2mv of delayed onset (~ 100 s) during the Control trial.  The ΔPO2mv (Baseline - Nadir) 
appeared to be lower for SNP vs. Control and L-NAME but the P value for ANOVA did not 
reach the a priori established significance level (P = 0.10).  In this context, the nadir PO2mv was 
significantly increased by SNP vs. Control (17.4 ± 1.2 mmHg vs. 13.0 ± 0.8 mmHg; P < 0.05), 
whereas the nadir PO2mv was lower during L-NAME (6.3 ± 0.8 mmHg) compared to Control 
and SNP (both P < 0.05).  Altogether, the PO2mv data indicate that SNP and L-NAME 
substantially altered the dynamics of the Q
.
O2-to-V
.
O2 ratio following the onset of muscle 
stimulations.   
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Discussion 
 
The most important original finding of the present investigation is that NO availability 
exerts a major influence over the ability to sustain PO2mv at rest and during contractions in the 
mixed-fiber type spinotrapezius muscle.  Specifically, in accordance with our first and second 
hypotheses increasing NO availability with SNP raised PO2mv (increased Q
.
O2/V
.
O2 ratio) during 
contractions whereas decreasing NO availability with L-NAME reduced PO2mv at rest and 
during contractions.  In addition, SNP slowed whereas L-NAME speeded the kinetics of PO2mv 
at the onset of contractions.  However, in contrast to our hypothesis SNP did not increase PO2mv 
in resting muscle when compared to control.  We believe that this effect resulted from SNP 
“leakage” into the systemic circulation which lowered the MAP.  It is pertinent that SNP 
increased the PO2mv/MAP ratio significantly as seen in Figure 4.2.  These results demonstrate 
that interventions that increase NO production and availability (e.g., exercise training) have the 
potential to increase PO2mv in contracting muscle.  By the same token, conditions that decrease 
NO production, and therefore availability, are expected to reduce PO2mv at rest and during 
muscle contractions.  These effects on PO2mv are important because this variable provides the 
driving force for blood-myocyte O2 transport. 
 
Correspondence with Existing Literature:  The PO2mv profiles from the control 
stimulations resembled closely those demonstrated previously in the spinotrapezius muscle from 
female Sprague-Dawley rats in our laboratory (Behnke et al., 2001; Behnke et al., 2002a; 
Diederich et al., 2002).  Accordingly, at the onset of contractions there was a significant delay 
(TD) where PO2mv remained at or close to resting baseline values followed by an exponential 
fall to the contracting steady state. 
To our knowledge there are no published data on the effects of either SNP or L-NAME 
on PO2mv in muscle.  Compared with the control conditions in the present investigation, SNP 
slowed (increased TD, τ and MRT) whereas L-NAME tended to speed (decreased τ and MRT, P 
= 0.1) the overall PO2mv response.  Moreover, L-NAME induced a pronounced fall in baseline 
PO2mv and distinctly altered the shape of the PO2mv response curve by driving PO2mv 
transiently below its steady-state level which necessitated use of a double exponential model to 
fit the data (Fig. 4.1B).  A similar transient fall of PO2mv below contracting steady-state levels at 
the onset of contractions has been found previously in the spinotrapezius muscle of old rats 
(Behnke et al., 2005), Type I diabetic rats (Behnke et al., 2002b) and rats with CHF (Diederich 
et al., 2002).  In addition, PO2mv kinetics are speeded in Type I diabetes [shorter TD and MRT 
(Behnke et al., 2002b)] and moderate CHF [shorter τ and MRT (Diederich et al., 2002)].  
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Mechanistic Bases for effects of Sodium Nitroprusside and L-NAME on PO2mv:   With 
SNP superfusion it was not possible to prevent a systemic vasodilation that reduced MAP 
significantly from ~120 to 90 mmHg.   Based on the assumption that the reduced MAP would 
decrease blood flow and therefore Q
.
O2 in proportion to the driving pressure and that the O2 
dissociation curve is linear across the range of PO2mv measured, we corrected the resting PO2mv 
for changes in MAP.  This is conceptually similar to calculations of vascular conductance and 
the results of this normalization (Fig. 4.2B) suggest that had MAP remained at control levels 
resting PO2mv would have been ~ 50% higher during SNP compared to control values, which is 
indirect evidence for substantial vasodilation of arteriolar resistance vessels.   
The kinetics of PO2mv reflect the dynamic matching between Q
.
O2 and V
.
O2.  Therefore, 
alterations in the temporal profile of increase in either Q
.
O2 or V
.
O2 will affect the kinetics of 
PO2mv.  Sodium nitroprusside will cause vascular smooth muscle relaxation and increase 
vascular conductance possibly leading to faster increase in Q
.
O2.  Moreover, augmented NO 
availability inhibits mitochondrial function directly and also by competing with O2 at the binding 
site on cytochrome oxidase [e.g., (Shen et al., 1994; Brown, 2000)].   Thus, the increased TD and 
slowed τ may have resulted from both an impairment of mitochondrial oxidative function 
(slower V
.
O2 kinetics) and faster increase in Q
.
O2 during contractions.  The compelling weight of 
evidence suggests that the early increase in Q
.
O2 (Phase I) is mediated by either a muscle 
pumping effect and/or a rapid vasodilation (Tschakovsky & Sheriff, 2004).  In this regard it is 
pertinent that Dobson & Gladden (2003) and Hamman et al. (2003) have both been unable to 
demonstrate the presence of a muscle pumping effect during contractions where the muscle is 
pre-vasodilated with adenosine.  Furthermore, increased NO availability may inhibit the 
production and/or action of endothelium-derived hyperpolarizing factor (EDHF, an important 
vasodilator pathway) (Nishikawa et al., 2000).  This would support the notion that the 
prolongation of TD and slowing of τ resulted from impaired V
.
O2 rather than faster Q
.
O2, at least 
across the first few seconds of contractions.   
In contrast to SNP, L-NAME superfusion did not alter MAP and at least by this criterion 
did not alter the perfusion pressure to the spinotrapezius muscle.  However, within the 
spinotrapezius muscle itself the decreased PO2mv at rest and more rapid fall at the onset of 
contractions indicated a reduced Q
.
O2-V
.
O2 ratio and a faster increase of V
.
O2 relative to Q
.
O2 
compared with control conditions.  Whereas in contracting human muscle the role of NO-
mediated vasodilation as the principal determinant of the Q
.
O2 kinetics (Radegran & Saltin, 1999) 
and steady-state Q
.
O2 (Joyner & Dietz, 1997) has been questioned, there is solid evidence that 
NO contributes significantly to resting and contracting muscle blood flow and thus Q
.
O2 in rats 
[e.g., (Hirai et al., 1995)].  In addition, the removal or reduction of inhibitory effects of NO on  
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mitochondrial oxidative function and thus V
.
O2 must be considered.  Specifically, NO blockade: 
1. speeds V
.
O2 kinetics at the onset of exercise in horses (Kindig et al., 2001; Kindig et al., 
2002a) and humans (Jones et al., 2003; Jones et al., 2004a; Jones et al., 2004b) but not in canine 
muscle (Grassi et al., 2005), and 2. increases V
.
O2 at rest and during contractions (Shen et al., 
1994).  The present investigation is the first to demonstrate that NO availability is critical for 
preserving the balance between Q
.
O2 and V
.
O2 such that the magnitude of the fall of PO2mv at the 
onset of contractions is constrained.   
As mentioned previously, the dynamic profiles of Q
.
O2 and V
.
O2 at the onset of 
contractions are different (Shoemaker & Hughson, 1999; Kindig et al., 2002b).  The dynamics of 
Q
.
O2 are biphasic with a close-to-instantaneous Phase I followed after several seconds by a 
slower Phase II that elevates Q
.
O2 to the steady state.  In contrast, V
.
O2 begins to increase 
essentially instantaneously from contractions onset in a close-to-monoexponential fashion 
(Behnke et al., 2002a; Grassi et al., 2002).  Behnke et al. (2002a) and Ferreira et al. (2005a) 
have modeled the effects of altering the magnitude and kinetics of Q
.
O2 on either PO2mv or 
venous O2 content.  Accordingly, several scenarios can account for the biphasic PO2mv 
(undershoot) that was apparent at the onset of contractions in the L-NAME condition.  These can 
be summarized as a slower increase and reduced amplitude of Q
.
O2 during Phase I and/or Phase 
II.  In each of these conditions, accelerated V
.
O2 kinetics and a greater steady-state V
.
O2 response 
will exacerbate the lowering of PO2mv across the transition.  Some insight into which of the 
above scenarios may be producing the PO2mv profile observed herein with L-NAME may be 
derived from consideration of whether NO-induced vasodilation contributes to Phase I or Phase 
II of the Q
.
O2 response.  Based on the results of Behnke et al. (2002a) and Ferreira et al. (2005a) 
the similar time delay, but faster time constant of PO2mv for L-NAME vs. Control, suggest that 
L-NAME caused a dynamic Q
.
O2-to-V
.
O2 mismatch primarily during Phase II of the Q
.
O2 
response.  As discussed above, Phase I is thought to be mediated by a muscle pumping effect 
and/or rapid vasodilation (Tschakovsky & Sheriff, 2004).  Sheriff & Hakeman (2001) 
demonstrated that L-NAME attenuated the increase in vascular conductance from 2-10 s 
following the onset of exercise in treadmill-running dogs.  However, the dynamic profile of 
increase in Q
.
 of running dogs is different from that observed in the rat-spinotrapezius muscle 
(Kindig et al., 2002b).  The latter has a biphasic response that more closely resembles the 
exercise hyperemia seen in exercising humans (Shoemaker & Hughson, 1999).  Thus, it is 
possible that in the spinotrapezius muscle NO-mediated vasodilation is a secondary response of 
delayed onset contingent upon shear stress-induced deformation of the vascular endothelium in 
addition to reduction of tonic sympathetic vasoconstriction that may be fiber-type dependent 
(sympatholysis, Thomas & Victor 1998).    
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Implications for understanding Vascular Control in Health and Disease:  The 
demonstration herein that NO synthase inhibition can reduce muscle PO2mv at rest and during 
contractions raises the possibility that derangements in NO availability might underlie the altered 
PO2mv profiles noted in aged muscle (Behnke et al., 2005) and that of individuals with Type I 
diabetes (Behnke et al., 2002b) and CHF (Diederich et al., 2002).  Each of these conditions is 
associated with endothelial dysfunction and/or reduced endothelial NO synthase [aging, 
(Woodman et al., 2002; Tanabe et al., 2003); Type I diabetes (Bagi & Koller, 2003); CHF, (Hirai 
et al., 1995; Didion & Mayhan, 1997)].  However, there is evidence that other sources of NO, 
notably neuronal and inducible NO synthase (nNO synthase and iNO synthase), may be 
regulated differently such that their contribution to intracellular NO availability is increased and 
contributes to pathological inflammatory effects (Hambrecht et al., 1999; Adams et al., 2003; 
Bojunga et al., 2004; Gielen et al., 2005) at the same time that vascular NO is reduced.  Thus it 
is conceivable that, unlike in the present investigation where L-NAME might have 
simultaneously decreased O2 delivery and increased O2 demand, pathological dysfunction in the 
NO synthase family may decrease both Q
.
O2 and V
.
O2 (via increased NO-mediated inhibition of 
mitochondrial function).  This would help reduce the disequilibrium between Q
.
O2 and V
.
O2 and 
constrain the fall in PO2mv.  However, as evident from the PO2mv undershoot seen in these 
conditions the matching between Q
.
O2 and V
.
O2 found in healthy muscle is not restored.  One 
consequence of this is that blood-myocyte O2 flux will be decreased and any resultant decrease 
in intracellular PO2 is expected to reduce intracellular energy levels (Wilson et al., 1977). 
 
Model Considerations:  Electrical stimulation induces a fiber recruitment pattern very 
different from that found in vivo, and the balance of mechanisms that increase Q
.
 and therefore  
Q
.
O2 may be very different from that found during voluntary exercise in humans.  However, the 
profile of PO2mv demonstrated in this and many other investigations [e.g., (Behnke et al., 2001; 
Behnke et al., 2002a; Behnke et al., 2002b; McDonough et al., 2005)] resembled closely that of 
femoral venous PO2 (Grassi et al., 1996; Bangsbo et al., 2000) and also estimates of muscle O2 
saturation assessed via near infrared spectroscopy in humans (Burnley et al., 2002; DeLorey et 
al., 2003; Grassi et al., 2003). 
The superfusion of pharmacological agents directly over the muscle is expected to 
minimize systemic effects because the active compounds would exert their effects within the 
spinotrapezius muscle with hopefully only minor systemic leakage through the circulation.  
Notwithstanding this, there was some leakage of SNP into the systemic circulation which caused 
a fall of MAP.  The normalization procedure used in Figure 4.2 attempts to allow for the  
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influence of this effect on muscle Q
.
 by recognizing that the lowered MAP will reduce Q
.
 and thus 
Q
.
O2 at any given level of vascular conductance.  This was not a problem with L-NAME as 
evidenced by the unchanged MAP maintained during superfusion of this compound.  Thus, the 
effects of L-NAME could be investigated herein without the confounding systemic effects on 
tonic sympathetic vasoconstriction that may have masked the effects of L-NAME in previous 
studies [for discussion see (Hirai et al., 1995)].   
It is recognized (and discussed above) that NO affects Q
.
O2 and V
.
O2 at different levels 
and in different directions.  It is possible, in a far more invasive preparation, to quantify the 
effect of altered NO availability on Q
.
O2 and V
.
O2 independently.  Unfortunately, the procedures 
necessary for making those measurements impose a severe risk of compromising the preparation 
and we therefore elected to examine the effects of altered NO availability unencumbered by 
more intrusive experimental interventions.  Hence, for the present investigation, we elected to 
focus on the principal criterion of blood-myocyte O2 transfer, PO2mv. 
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Conclusions 
 
Despite the plethora of vasodilatory mechanisms that facilitate an increased blood flow 
and oxygen delivery (Q
.
O2) at the onset of muscle contractions, in electrically-stimulated rat 
spinotrapezius muscle the NO pathway appears to represent an integral component of the Q
.
O2-
to-V
.
O2 matching, during the steady-state and transitional phase of muscle contractions, that 
ensures maintenance of a high PO2mv.  Decreases in NO availability that may occur in aged 
muscle or secondary to chronic diseases such as diabetes or CHF have the potential to cause the 
altered PO2mv profiles and reduced O2 driving pressure described for those conditions (Behnke 
et al., 2002b; Behnke et al., 2005; Diederich et al., 2002).  Mechanistically, the decrease of 
PO2mv induced by diminished NO availability described herein may initiate a cascade of 
responses that impair muscle performance including a reduced blood-myocyte O2 flux, lowered 
intracellular PO2 and decreased cellular energy levels.    
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Figure 4.1. Microvascular PO2 response from a representative animal 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Microvascular PO2 response from a representative animal under control, 
sodium nitroprusside (SNP) and L-NAME (L-nitro arginine methyl ester).  Panel A presents the 
raw data. Panel B shows the same response as in A with best regression fit (solid thick lines).  
Time zero denotes onset of muscle contractions.  Compared with the Control response (mean 
response time, MRT = 24 s) PO2mv dynamics were slower during SNP (MRT = 29 s), while 
during L-NAME PO2mv kinetics were speeded (MRT = 19 s) and PO2mv fell transiently below 
the end contractions value.  The increase in PO2mv after reaching its nadir occurs as a 
consequence of V
.
O2 approaching the steady-state (or diminished rate of increase) while Q
.
O2 
continues to increase towards its final steady-state value (i.e., slower kinetics of Q
.
O2 vs. V
.
O2). 
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Figure 4.2. Microvascular PO2 response normalized to mean arterial pressure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. Panel A:  Microvascular PO2 response from Figure 4.1 normalized to mean 
arterial pressure (MAP) during each treatment.  In addition, to illustrate and facilitate 
visualization of the effects of SNP and L-NAME on PO2mv responses the data were normalized 
to the baseline (BSL, pre-contracting) value of PO2mv/MAP during superfusion with Krebs-
Henseleit (Control).  Panel B:  Ratio of microvascular PO2-to-MAP for all seven rat 
spinotrapezius muscles.  The data are normalized to Control values. * Significantly different 
from Control. # Significantly different from SNP. 
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Figure 4.3. Kinetics of microvascular PO2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Kinetic parameters describing the microvascular PO2 (PO2mv) response at 
rest and in response to 1 Hz stimulation.  BSL, Baseline; Δ, decrease in PO2mv from baseline to 
nadir; End Stim., end of stimulation; TD, time delay; τ, time constant; MRT, mean response time 
(TD + τ). * P < 0.05 vs. Control; # P < 0.05 vs. L-NAME; σ P = 0.10 vs. Control.   
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CHAPTER 5 - Frequency domain characteristics and filtering of 
blood flow following the onset of exercise: implications for kinetics 
analysis 
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Summary 
 
Typically, the kinetics of blood flow (BF) are determined with data processing methods 
that yield poor kinetics characterization (i.e., large confidence intervals).  In this study we 
examined the validity and usefulness of a low pass filter (LPFILTER) to reduce point-to-point 
variability and enhance parameter estimation of the kinetics of BF.  Computer simulations were 
used to determine the power spectrum (Fast Fourier Transform) of simulated responses.  In 
addition, we studied the leg BF response to a single transition in four subjects during supine 
knee-extension exercise using three methods of data processing [Beat-by-Beat, average of 3 
cardiac cycles (AVG3 BEATS) and LPFILTER].  Femoral artery blood velocity was measured by 
Doppler ultrasound [and converted to flow using resting values of femoral artery diameter].  The 
power spectrum of BF, which contained the kinetics information (≤0.2 Hz) did not overlap with 
the main sources of ‘noise’ (muscle contraction and cardiac cycle) in either simulated responses 
or Doppler measurements.  For the data from 4 subjects, there were no significant differences 
between the parameter estimates for a 2 exponential fitting function using Beat-by-Beat, AVG3 
BEATS and LPFILTER (P > 0.05).  However, LPFILTER (cutoff = 0.2 Hz) resulted in a significantly 
lower standard error of the estimate (SEE) for all parameters (P < 0.05).  The means ± SD for the 
SEE of time-related parameters for Beat-by-Beat, AVG3 BEATS and LPFILTER were: time constant-
phase 1 = 5.0 ± 1.1 s, 4.5 ± 2.1 s and 0.3 ± 0.2 s; time delay-phase 2 = 17.8 ± 7.9 s, 12.8 ± 7.5 s 
and 1.4 ± 1.4 s; time constant-phase 2 = 15.8 ± 4.6 s, 9.9 ± 2.9 s and 1.1 ± 0.5 s, respectively.  In 
conclusion, LPFILTER appeared to be a valid procedure providing the highest signal-to-noise ratio 
while maintaining original data density.  This resulted in better kinetic characterization of BF 
response (i.e., smallest confidence interval for parameter estimates). 
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Introduction 
 
The redundancy of processes associated with the muscle blood flow response to exercise 
(Laughlin & Korzick, 2001; Clifford & Hellsten, 2004) has necessitated the use of kinetics 
analysis to across the rest-to-exercise transition to discern the relative contribution or importance 
of select vasodilatory mechanisms.  In this context, Doppler ultrasound has been used to measure 
the dynamics of blood flow response in humans (Shoemaker et al., 1994) and animals 
(Buckwalter et al., 1998).  In spite of good signal acquisition (i.e., little measurement error), 
these measurements are characteristically ‘noisy’ during exercise due to cardiac cycle and 
contraction-induced oscillations in blood flow (Lutjemeier et al., 2005) (see Fig 5.1).  This is 
relevant for data interpretation because to make physiological inferences from kinetic parameters 
and to compare the effects of interventions on control processes it is paramount that the 
confidence interval for parameter estimation be as narrow as possible.  In general, the signal-to-
noise ratio and density of data across the transition phase (see Discussion) are the main factors 
affecting the confidence of parameter estimation of kinetics responses (Lamarra et al., 1987). 
The kinetics of blood flow are characterized by a fast increase (Phase 1) followed by a 
slower response beginning ~10-20 s after the onset of exercise (Phase 2) [rev (Shoemaker & 
Hughson, 1999)].   This biphasic characteristic and rapid early response increases the sensitivity 
of parameter estimation (and the confidence interval) to the method used for kinetics analysis.  
Several methods have been used to pre-process the raw data [e.g., beat-by-beat (Fukuba et al., 
2004) and contraction-relaxation cycle (Saunders et al., 2005)].  Beat-by-beat data has a 
temporal resolution that seems adequate for determining blood flow kinetics; however, the low 
signal-to-noise ratio leads to unacceptably high confidence intervals for the resulting parameter 
estimates.  Conversely, averaging the blood flow response over a contraction-relaxation cycle 
will improve the signal-to-noise ratio, but with the undesirable effect of reducing the density of 
data across the transition phase, which might prevent adequate determination of the fast 
responding processes (Phase 1).  Ensemble-averaging of multiple exercise replicates has also 
been used to improve the signal-to-noise ratio and accentuate the kinetic features [e.g., 
(MacDonald et al., 1998; Koga et al., 2005; Saunders et al., 2005)].  However, to achieve 
acceptable confidence intervals for ‘noisy’ responses such as blood flow, it may be necessary to 
ensemble-average an unreasonable number of transitions (see Discussion) (Lamarra, 1990).  This 
would severely limit the utility of this approach in scenarios like patient evaluation where only a 
limited number of transitions are feasible.     
To date there is no method that achieves an optimal balance between signal-to-noise ratio 
and data density to accentuate the underlying kinetics of blood flow and, consequently, provide  
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narrow confidence intervals of parameter estimates.  In this context, filtering the blood flow data 
in the frequency-domain might be an alternate option to time-domain filtering (beat-by-beat and 
contraction-relaxation cycle); however, this approach requires minimal overlap between the 
frequency spectrum of the underlying kinetics response and the main sources of ‘noise’ in blood 
flow.  To the best of our knowledge, the frequency-domain characteristics of the oscillatory 
components of blood flow and the underlying kinetic response have not been determined.   
The purpose of the present study was to examine the validity and usefulness of filtering 
blood flow data in the frequency-domain prior to characterizing the kinetic response.  We 
hypothesized that the main sources of ‘noise’ in blood flow during exercise would be muscle 
contraction and cardiac cycle (Walloe & Wesche, 1988; Radegran & Saltin, 1998; Lutjemeier et 
al., 2005) (for example see Fig. 5.1), and that the frequency content of these oscillations would 
not overlap with the frequency range of the slower processes determining the underlying kinetics 
response because, in general, contraction frequency and heart rate are high-frequency processes.  
This would permit the application of a low pass filter to the raw Doppler blood flow data in 
which the higher frequencies associated with muscle contraction and cardiac cycle would be 
eliminated.  The advantage of this filtering procedure would be a lower standard error of the 
estimate for the parameters of frequency-domain filtered data compared to those obtained with 
time-domain methods, representing a substantial improvement in the confidence interval for each 
kinetic parameter. 
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Methods 
 
Computer simulations:  The dynamic (and biphasic) increase in blood flow following the 
onset of exercise was simulated with exponential equations.  The default parameter values for 
simulations were Baseline = 0.5 a.u., A1 = 2 a.u., A2 = 3 a.u., τ1 = 2 s, TD2 = 15 s and τ2 = 15 s 
(see Eq. 1), similar to a previous computer modeling study (Ferreira et al., 2005a).  For 
simulations of responses without noise the physiologically relevant parameter values are A1 as 
percentage of total amplitude (Atot = A1 + A2), τ1, TD2 and τ2.  For these parameters our default 
values are in agreement with results observed in healthy subjects (Radegran & Saltin, 1998; 
MacDonald et al., 1998; Saunders et al., 2005).   
The oscillations in leg blood flow superimposed on the underlying kinetics response were 
simulated by a sinusoidal function [y(t) = A·sin(360 t /T)], where A = mean-to-peak amplitude 
and T = period of oscillations (i.e., T = 1/f where f is frequency of oscillations).  The known 
sources of oscillations at rest and exercise are cardiac frequencies (Radegran & Saltin, 1998), 
very low frequency oscillations (Wray et al., 2004) and muscle contraction (Walloe & Wesche, 
1988; Radegran & Saltin, 1998; Lutjemeier et al., 2005).  For both heart rate (100 beats·min
-1, f = 
1.67 Hz) and muscle contraction (40 min
-1, f = 0.67 Hz) we simulated A = 2 a.u, which 
represented oscillations equal to 80% of the simulated increase in blood flow from rest-to-
exercise.  The mean-to-peak amplitude of the very low frequency oscillations (6 min
-1, f = 0.1 
Hz) was arbitrarily set as 0.5 a.u..  In addition, we simulated the existence of random noise 
(range - 0.75 to 0.75 a.u.) on blood flow measurements.  The oscillatory components and random 
noise were added to the underlying simulated biphasic increase in ‘mean’ blood flow to 
qualitatively approximate the raw data of Doppler ultrasound measurements during rest and 
exercise.  It is important to note that a constant heart rate was simulated for the rest-to-exercise 
transition.  Clearly, these simulations are an oversimplification of the real blood flow response; 
however, they permit examination of the effects of known sources of noise on the time- and 
frequency-domain characteristics of leg blood flow response to exercise. 
 
Human studies:  The experiments were conducted in 4 healthy individuals (2 men and 2 
women, age 28 ± 9.0 yrs and body mass 65.8 ± 13.8 kg).  The protocol was explained in detail to 
each subject, who signed a consent form after reading a description of the study.  The subjects 
were familiarized with the exercise protocol from participation in previous studies in the 
laboratory.  The study was approved by the Institutional Review Board for Research Involving 
Humans Subjects at Kansas State University.  
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The protocol consisted of supine single-leg knee-extension exercise (2 min rest + 6 min 
exercise) performed at a light-to-moderate work rate so as to achieve a steady state of 
cardiovascular variables.  The knee-extension exercise was performed at a contraction rate of 40 
min
-1. To maintain the desired cadence the subjects were aided by the signal from a metronome, 
which was started at the beginning of the resting period to avoid anticipatory responses.  Subjects 
performed one rest-to-exercise transition.  One subject returned to the laboratory on two different 
days (in addition to the initial visit) to complete several transitions to the same work rate as 
performed on the first day in order to establish reproducibility.  In two visits the subject 
performed two transitions, with 25-30 min of recovery between each transition, yielding a total 
of 5 exercise bouts (three days) at the same work rate. 
Femoral artery blood velocity (BV) was measured by pulsed-wave Doppler ultrasound 
(Model 500V, Multigon Industries, Mt Vernon, NY) using a 4-MHz probe with fixed angle of 
insonation of 45º and full gate width.  The Doppler probe was placed above the common femoral 
artery of the right (exercising) leg ~2-3 cm proximal to the femoral artery bifurcation.  The probe 
position was determined by echo-Doppler ultrasound.  The audio signal was processed and 
converted to velocity as described in detail by Lutjemeier et al. (2005).  The data were collected 
at 200 Hz and stored for offline analysis.  To calculate beat-by-beat blood velocity (and flow), 
the 200 Hz data were integrated over each R-R interval of the ECG determined by a modified 
Lead I configuration.  Femoral artery diameter was measured at rest by echo-Doppler ultrasound 
(Vivid 3-Pro, GE) with a 7.5-MHz linear probe.  Previous studies have shown that femoral artery 
diameter did not change significantly during exercise (Radegran, 1997; DeLorey et al., 2004c; 
MacDonald et al., 1998).  Thus, resting diameter was used to calculate leg blood flow (LBF), 
where LBF = BV·πr
2 (BV in cm·s
-1 and r is femoral artery radius in cm) and was multiplied by 
0.06 to convert from ml·s
-1 to L·min
-1.  
 
Spectral Analysis and Filtering: A fast Fourier transform [FFT, Cooley-Tukey’s 
algorithm - Hanning window (Yamamoto & Hughson, 1993)] was used to examine the frequency 
domain (spectral) characteristics of the simulated and directly measured blood flow response to 
exercise.  Spectral analyses were done on data sets with 15 s of rest and 180 s of exercise (rest-
to-exercise transition).  This time window included ~90-120 s of ‘steady state’.  The Fourier 
transform assumes stationary data and inclusion of the dynamic increase in blood flow violates 
this assumption.  However, this analysis was important to establish the range of spectral 
frequencies containing information on the biphasic kinetics of blood flow (see Results) and to 
determine the cutoff frequency for filtering the data.  
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The spectral analysis of blood flow responses (computer simulations and in vivo 
measurements) demonstrated that the frequency range containing the kinetics information did not 
overlap with higher frequency ‘noise’ such as those induced by heart rate and muscle contraction 
(see Results).  Thus, a frequency-domain filtering procedure was used to eliminate the higher 
frequency noise (i.e., low pass filter).  The filtering was done using a default low pass function of 
SigmaPlot (lowpass.xfm - SigmaPlot 2001, Systat Software Inc, CA).  The cutoff for filtering 
was titrated to produce the lowest ‘noise’ while retaining data with frequencies fundamental for 
describing the biphasic kinetics of blood flow.  To examine the effects of filtering on the 
underlying kinetics response we applied the low pass filter (LPFILTER) on computer simulated 
data, filtering out frequencies ≥ 0.1 and 0.2 Hz (i.e., eliminating 99.9% and 99.8% of high 
frequencies, respectively,  for 200 Hz data).  The cutoff frequency determined by this analysis 
was then used for filtering the raw Doppler blood flow data for kinetics analysis.  
 
Kinetics Analysis:  The raw Doppler data from 5 transitions of one subject were time 
aligned to the onset of exercise and ensemble-averaged to produce a single data set.  For these 
transitions, a low pass filter (LPFILTER; cutoff  f = 0.2 Hz) was then applied to the 200 Hz 
ensemble-averaged data.  Finally, the data were resampled at 10 Hz for nonlinear regression 
analysis, i.e., from the 200 Hz data set we retrieved every 20
th datum).  The resampling was 
necessary because using a personal computer for curve-fitting of a single response with 36,000 
data points (180 s at 200 Hz) with a 2 exponential model would usually take 30-45 min and 
frequently lock up the computer before achieving the convergence criteria of the nonlinear 
regression.  Importantly, for data sets in which the curve-fitting could be successfully completed 
at 200 Hz we observed that the parameter estimates of blood flow kinetics (see Eq. 1 below) for 
10 Hz (resampled) data were, within round-off error, almost identical to the 200 Hz data.  The 
Beat-by-Beat data were interpolated (zero-order interpolation) at 10 Hz and ensemble-averaged 
for analysis of blood flow kinetics.    
The kinetics of blood flow for a single transition of each subject (visit 1) were determined 
for the Beat-by-Beat, average of 3 consecutive beats (AVG3 BEATS) and LPFILTER of raw Doppler 
data.  For the latter, the Doppler data (200 Hz) were filtered and resampled at 10 Hz as described 
above.  The time course of leg blood flow was determined by nonlinear regression using a least-
squares technique (SigmaPlot 2001, Jandel Scientific).  A two-component model was used to 
describe the response (Shoemaker et al., 1996b; MacDonald et al., 1998; Radegran & Saltin, 
1998; Koga et al., 2005) 
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  LBF  =  LBFBSL + A1·(1-e
-(t-TD1)/τ1)  (Phase  1)    (1) 
   +   A 2·(1-e
-(t-TD2)/τ2)   (Phase  2)   
 
where BSL = baseline, A = amplitude, TD = time delay, and τ = time constant of each 
phase of the LBF response.  The nonlinear regression results of interest for this study were the 
parameter estimate (PE) describing the LBF kinetics, and the standard error of the estimate 
(SEE) for each parameter, which describes the confidence of parameter estimation.  A reduction 
in the SEE represents a decrease, and therefore improvement in the confidence interval for 
estimation of kinetic parameters. 
 
Statistical Analysis:  The PE and SEE for blood flow kinetics were determined from 
nonlinear regression analysis (Marquadt-Levenberg algorithm, SigmaPlot 7.01, Systat Software) 
of data pre-processed with the three different methods (Beat-by-Beat, AVG3 BEATS and LPFILTER).  
The SEE for Beat-by-Beat, AVG3 BEATS and LPFILTER were compared by one-way ANOVA.  The 
Fisher-LSD test was used for post-hoc analysis.  Significance was declared when P < 0.05.  Data 
are presented as mean ± standard deviation.  
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Results 
 
The time- and frequency-domain characteristics of the simulated blood flow response are 
shown in Fig. 5.2.  The spectral analysis of simulated blood flow + ‘noise’ identified the three 
simulated oscillatory components (as expected) and a lower frequency component (in the range 0 
to 0.1 Hz), which appeared to contain the information about the underlying kinetics response.  
However, filtering the data by removing frequencies greater than 0.1 Hz distorted the simulated 
blood flow (Fig. 5.3).  As shown in Table 1, we observed that within the range of kinetic 
parameters previously described for blood flow response in healthy subjects (Radegran & Saltin, 
1998; MacDonald et al., 1998; Saunders et al., 2005) a cutoff frequency of 0.2 Hz retained 
sufficient frequency information so as to accurately characterize the biphasic kinetics of blood 
flow including the transitional changes at exercise onset (Fig. 5.3, lower inset) and the Phase I-II 
transition (Fig. 5.3, upper inset).   
To further examine the validity of our simulations and establish reproducibility we 
determined the frequency characteristics of the raw Doppler data from a single-transition and 
from 5 transitions ensemble averaged (Fig. 5.4).  The power spectrum of these responses 
qualitatively resembled the computer simulations.  Moreover, the overall frequency-domain 
characteristics of each transition were grossly similar (Fig. 5.5).  The primary effect of ensemble-
averaging several transitions was a reduction in the power of components with frequencies > 0.1 
Hz (Fig. 5.4B), which is in effect qualitatively similar to a low-pass filter with cutoff of ~ 0.1 to 
0.2 Hz.  
The effects of LPFILTER on the raw Doppler data ensemble-averaged are shown in Fig. 6.  
As predicted by the computer simulations, the LPFILTER eliminated the primary sources of ‘noise’ 
and revealed the underlying biphasic increase in LBF.  This noise-reducing effect was greater 
than that achieved by ensemble-averaging five transitions (after 10 Hz interpolation) of Beat-by-
Beat data (Fig. 5.6C).  The LPFILTER was applied to each of the five transitions and their kinetics 
were determined (Table 5.1).  For each of the 5 transitions the overall kinetics (mean response 
time, MRT) of leg blood flow after LPFILTER were virtually identical to the corresponding raw 
(unfiltered) Doppler data when both were analyzed by a monoexponential function (Table 5.2).  
These results demonstrate that LPFILTER did not slow the overall kinetics of blood flow, which is 
a concern with any filtering procedure. The CV for baseline and steady state blood flow was 
<10%, which is similar to a previous study in our laboratory (Lutjemeier et al., 2005).  However, 
the CV for each kinetic (i.e., time-dependent) parameter ranged from 12 to 67%, suggesting 
substantial day-to-day variability.  
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The mean work rate for a single transition performed by 4 subjects was 10.3 ± 2.6 W, 
which elicited a mean heart rate equal to 89.0 ± 9.4 bpm and leg blood flow of 1.32 ± 0.23 
L·min
-1 at the steady state of exercise.  A representative response showing the three methods of 
data processing used for kinetics analysis (Beat-by-Beat, AVG3 BEATS and LPFILTER) is depicted 
in Fig. 5.7.  The parameter estimates describing the blood flow response for each method were 
not significantly different (Table 5.3).  However, the SEE for each parameter was significantly 
lower for LPFILTER compared to Beat-by-Beat and AVG3 BEATS (Fig. 5.8).  The LPFILTER method 
decreased the SEE by 85-95% compared to Beat-by-Beat and AVG3 BEATS. 
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Discussion 
 
In the present study we examined, for the first time, the time and frequency domain 
characteristics of arterial blood flow responses following the onset of exercise.  The principal 
and novel findings were that the low frequency range (< 0.5 Hz) of the power spectrum 
contained the information necessary to describe the biphasic kinetics of blood flow adjustment, 
and that the primary sources of ‘noise’ in Doppler measurements (muscle contraction and cardiac 
cycle) occurred at higher frequencies, and thus did not overlap with the frequency spectrum of 
the blood flow kinetics.  These observations provided the bases for applying a low pass filter 
(cutoff = 0.2 Hz) to the Doppler blood flow data.  For single rest-exercise transitions, the 
LPFILTER method produced the lowest noise with highest temporal resolution compared to 
processing the data as Beat-by-Beat and AVG3 BEATS.  The implications for kinetics analysis were 
a significant reduction in the standard error of the estimate and, therefore, improvement in the 
95% confidence interval for each kinetic parameter. 
The ensemble averaging of blood flow from several similar transitions to reduce the 
sample-to-sample variation and improve kinetic parameter estimation is made under the premise 
that the sample-to-sample variation has a normal distribution (i.e., Gaussian or ‘white’ noise); 
however, the frequency analysis of raw Doppler data suggests that the variability in blood flow is 
non-white noise.  Even though we have not performed a thorough analysis of time-domain 
‘noise’ distribution as previously done for pulmonary V
.
O2 and PCr (Lamarra et al., 1987; 
Rossiter et al., 2000), a fundamental characteristic of ‘white (Gaussian) noise’ is the uniform 
distribution of power in the frequency spectrum.  Therefore, the non-Gaussian properties of 
blood flow noise were evidenced by distinct peaks encountered in the power spectrum associated 
with muscle contraction and cardiac cycle (Fig. 5.4), which agreed nicely with the results from 
computer simulations (Fig. 5.2).  For Doppler measurements, the ‘noise’ related to muscle 
contraction showed a narrow frequency range, suggesting small variations in contraction 
frequency, and the greatest power spectral density.  In contrast, the spectral characteristics of 
oscillations induced by cardiac cycle demonstrated a wide frequency range, which reflected the 
dynamic increase in heart rate following the onset of exercise (rest 60 ± 3.1 bpm, exercise 89 ± 
9.4 bpm).  The most important observation, however, was that the contraction and cardiac cycle 
‘noise’ did not overlap with the power spectrum describing the underlying dynamic increase in 
blood flow.  This is a pre-requisite to apply the LPFILTER because in the presence of overlap the 
cutoff frequency necessary to eliminate the primary sources of noise would also filter out 
frequency components essential to describe the underlying kinetics and, therefore, distort the 
response (e.g., Fig. 5.3).  Based on comparison of kinetics of simulated and filtered responses  
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(Table 5.1 and Fig. 5.3) we chose a cutoff frequency = 0.2 Hz for LPFILTER because a lower 
cutoff (e.g., 0.1 Hz) distorted the phase 1 of blood flow leading to results that differed by more 
than 10% from the simulated value.  However, we acknowledge that the ‘optimal’ cutoff 
frequency for LPFILTER will vary according to the underlying kinetics of blood flow (Table 5.1); 
thus, the cutoff frequency must be tailored to the characteristics of each type of response. 
On the basis of the non-Gaussian distribution of blood flow noise it is possible that 
ensemble averaging might actually enhance the underlying oscillatory characteristic induced by 
muscle contraction and cardiac cycle instead of eliminating these oscillations and improve the 
signal-to-noise ratio for kinetics analysis.  However, we observed that ensemble-averaging 5 
transitions substantially reduced the ‘noise’ in the raw Doppler data (Fig. 5.4A).  This might be 
explained by the fact that after time alignment of each transition for the onset of exercise the 
occurrence of muscle contraction and heart beat are not superimposable from test-to-test due to 
the within-subject variability of heart rate (baseline, steady state and dynamics) and timing of 
muscle contraction.  In the frequency domain, averaging several like transitions reduced the 
power spectrum of high frequency components.  This was evidenced by a 75% reduction in the 
area under 0.6 to 0.7 Hz and a 60% reduction for 1.10 to 1.50-Hz, but a similar area under the 
frequency spectrum for 0 to 0.2 Hz (Fig. 5.4B). Thus, ensemble averaging blood flow data 
worked in a manner similar to, but less effective than, a low pass filter in diminishing the 
sample-to-sample variability. 
To eliminate or reduce the ‘noise’ of blood flow measurements so as to improve the 
precision of estimating the kinetic parameters of blood flow, investigators have used different 
approaches for data processing [beat-by-beat (MacDonald et al., 1998; Fukuba et al., 2004; Koga 
et al., 2005), 1 s time bins (Shoemaker et al., 1996b; Shoemaker et al., 1994) and averaging over 
a contraction-relaxation cycle (Shoemaker et al., 1996a; Radegran & Saltin, 1998; Saunders et 
al., 2005)].  These strategies are based on the observations of Lamarra et al. (1987), who defined 
the confidence interval for τ or TD (K1) as  
        
          ( 2 )  
 
where S0 is the standard deviation of the fluctuations around the mean (‘noise’), ΔYSS is the 
amplitude of increase in the investigated variable from baseline to steady state exercise (‘signal’) 
and L ^ is determined by the time L ^ constant and data density.  Therefore, decreasing the standard 
deviation by averaging data over longer time bins (Osada, 2004; Shoemaker et al., 1996c) will 
improve (i.e., decrease) the confidence interval of parameter estimation.  However, these 
averaging procedures have the limitation of decreasing the temporal resolution for kinetics 
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analysis (i.e., increase in L ^ ), which is frequently overlooked in the context of kinetics analysis.      
  The kinetics of blood flow following the onset of exercise are biphasic (Eq. 1) with an 
initial fast component (τ1 ~ 1-5 s) followed by a slower response (τ2 ~10-40 s) that starts or 
emerges 10-30 s after the start of exercise [rev. (Shoemaker & Hughson, 1999)].  The fast phase 
1 of blood flow appears to be crucial for maintaining adequate O2 delivery following the onset of 
exercise (Ferreira et al., 2005a); therefore, these kinetics need to be adequately characterized.  
The theoretical predictions of Lamarra et al. (1987) indicated that for a fixed noise and sampling 
frequency, the confidence interval of τ improves as the kinetics becomes slower due to the 
increase in density of data across the transition phase.  This has direct implications for 
investigation of blood flow kinetics because the rapidity of the early response (τ1) and phase 1-
phase 2 transition (TD2 in Eq. 1), and the relatively low amplitude of phase 1 (~ 50% of total for 
moderate exercise) requires high sampling frequencies to determine the biphasic kinetics with 
acceptable degree of confidence.  In this setting, the 95% CI of the kinetic parameters will be 
very sensitive to the averaging procedure.  This was demonstrated in the present study by 
comparing three methods (Beat-by-Beat, AVG3 BEATS and LPFILTER) to process the blood flow 
data prior to kinetics analysis.    
The simplest and most logical averaging of blood flow data is over a cardiac cycle (Beat-
by-Beat); however, the resulting profile has a low signal-to-noise ratio (CV = 33%, Fig. 5.7A) 
that results in large SEE for kinetic parameters (Fig. 5.8) and in some occasions has masked the 
biphasic nature of the blood flow response to exercise (Fukuba et al., 2004).  In the present 
study, the Beat-by-Beat method demonstrated a waxing and waning of the ‘noise’ in blood flow 
(Fig. 5.7A) likely because the heart beat occurred during muscle relaxation at some points 
generating large oscillations in flow, but at other periods the cardiac cycle coincided with muscle 
contraction generating small oscillations (Walloe & Wesche, 1988; Radegran & Saltin, 1998; 
Osada, 2004; Lutjemeier et al., 2005) (e.g., Fig. 5.1).  The procedure of averaging over longer 
time bins is of diminishing return because the decrease in the standard deviation (S0) is 
counterbalanced by a reduction in data density (leading to an increase in L ^ , see Eq. 2).  
Accordingly, AVG3 BEATS showed a small decrease in the SEE that was not significantly different 
from Beat-by-Beat for most kinetic parameters (Fig. 5.8); however, with inclusion of more 
subjects these differences would probably reach significance.  In contrast to time-domain 
filtering, LPFILTER provided an excellent combination of a decrease in blood flow ‘noise’ while 
maintaining high temporal resolution for kinetics description (which would tend to minimize L ^ in 
Eq. 2).  These effects were confirmed by the very low SEE of each kinetic parameter (Fig. 5.8).  
For all parameters the SEE of LPFILTER was significantly lower than Beat-by-Beat and         
AVG3 BEATS, demonstrating a substantial improvement in the 95% CI.    
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The improvement in the 95% CI is relevant for comparison of kinetic parameters between 
separate transitions, and becomes more critical when investigators are limited to single-
transitions such as in pharmacological and clinical studies of blood flow kinetics [e.g. 
Shoemaker et al., 1996a; Shoemaker et al., 1999].  However, a shortcoming of single transitions 
is the potential for within-day and day-to-day variability of the “true” underlying kinetic 
parameters for a given subject.  Even with good compromise between signal-to-noise ratio and 
data density obtained by LPFILTER, we observed a large within-subject variability of kinetic 
parameters determined for 5 transitions collected over three days (Table 5.1).  This suggests that 
ensemble-averaging of multiple transitions may still be necessary to minimize variability and 
accentuate the underlying physiological response.  For the subject that repeated 5 transitions, we 
also compared the effects of LPFILTER to beat-by-beat data (10-Hz interpolated) ensemble-
averaged.  As previously shown (Lamarra et al., 1987; Rossiter et al., 2000), the effects of 
ensemble-averaging data with low signal-to-noise ratio on the 95% CI is limited because the 
latter will be improved by a factor of 1/√n, where n is the number of repetitions (Lamarra et al., 
1987; Rossiter et al., 2000).  For example, for the blood flow response shown in Fig. 5.6, in 
order to obtain a 95% CI for beat-by-beat data (10-Hz interpolated) similar to that achieved with 
LPFILTER for a given parameter (τ or TD), it would be necessary to average approximately 225 
more transitions (estimated from Lamarra et al., 1987).  This further emphasizes the advantage 
of using LPFILTER to process blood flow data for kinetics analysis irrespective of using single or 
multiple transitions ensemble-averaged (Figs. 5.6-5.8). 
The present analysis was conducted with supine one-leg knee extension exercise of 
moderate intensity at 40 contractions·min
-1, thus, the possibility to extrapolate our results to 
different exercise modes, intensities and contraction frequencies must be considered.  Compared 
to our results for supine knee-extension exercise, other exercise modes may result in differences 
in amplitude and kinetics of the blood flow response.  From the perspective of frequency analysis 
the total amplitude of blood flow response is a “dc shift” located at 0 Hz on the power spectrum 
and, thus, would not be affected by LPFILTER.  Hence, the major concern for extrapolating our 
results to other exercise modalities, intensities or contraction frequencies is the kinetics (i.e., 
time-dependent characteristics) of the adjustment in blood flow.  Specifically, situations where 
blood flow kinetics are substantially faster than examined herein will require higher cutoff 
frequencies to avoid distortion of the kinetic response (Table 5.1 and Fig. 5.3).  With regard to 
contraction frequency, the applicability of our results will depend on the effects of contraction 
frequency on blood flow kinetics.  If we assume, for example, that BF kinetics are independent 
of contraction frequency, our data would suggest that ~15 contractions·min
-1 (or 0.25 Hz) is the 
lower limit to be able to apply the LPFILTER with a cutoff = 0.2 Hz (i.e., eliminating the frequency  
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components ≥12 min
-1).  However, there is no upper limit for contraction frequency because 
LPFILTER will eliminate all high frequency components.  Likewise, heavy exercise is 
characterized by the existence of a slow increase in blood flow after phase 2 (Koga et al., 2005; 
Poole et al., 1991), which will not limit the use of LPFILTER because the frequency components 
describing this process are lower than 0.2 Hz (i.e., time constant longer than the kinetics of phase 
2) and, thus, retained after applying the LPFILTER.  Therefore, the filtering procedure used in the 
present study should be valid for different exercise modes and intensities.  However, for low 
contraction frequencies the most appropriate cutoff frequency will depend on the effects of 
contraction frequency on blood flow kinetics. 
As for blood flow, there has been great interest in the kinetics of minute ventilation, 
pulmonary O2 uptake (DeLorey et al., 2004c; Fukuba et al., 2004; Koga et al., 2005; Lamarra et 
al., 1987; Rossiter et al., 2000) and phosphocreatine (from 
31P-MRS) (e.g., Rossiter et al., 2000).  
Is it possible to use the LPFILTER to reduce the noise of pulmonary O2 uptake or phosphocreatine 
and thereby decrease the number of trials needed to improve the confidence of kinetics analysis?  
These variables have Gaussian distribution of noise (Lamarra et al., 1987; Rossiter et al., 2000), 
thus, we anticipate uniform distribution of noise on their frequency spectrum, suggesting that 
application of the LPFILTER might be possible.  However, it would require a different strategy of 
data processing because, for example, pulmonary O2 uptake data is a time series where each 
breath is a discrete event of variable duration, in contrast to the analog blood flow using Doppler 
ultrasound, which can be evenly sampled in time. 
  
Limitations:  In the current study we assumed constant femoral artery diameter from rest 
to exercise to calculate blood flow from Doppler measurements of blood velocity.  However, as 
mentioned above, femoral artery diameter did not change significantly during knee-extension 
exercise (Radegran, 1997; DeLorey et al., 2004c; MacDonald et al., 1998). 
It was outside the scope of our study to establish a generic cutoff frequency for low pass 
filtering of blood flow data for kinetics analysis.  However, we observed that using a cutoff = 0.5 
Hz dramatically reduced the ‘noise’ observed for direct measurements of blood flow while the 
fast responding characteristics of simulated responses were preserved.  In fact, a cutoff frequency 
= 0.5 Hz also resulted in very low standard error of estimate for the kinetic parameters of blood 
flow from 5 transitions ensemble-averaged (1.0 - 4.7 % for 0.5 Hz vs. 0.4 - 3.5 % for 0.2 Hz, see 
Table 5.4) but investigators must keep in mind that this cutoff frequency would only be 
appropriate for exercise performed with a muscle contraction frequency greater than 30 min
-1 
(see above).  
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The large within-subject variability of blood flow kinetics (Table 5.2) poses a limitation 
for using a single transition to compare the effects of Beat-by-Beat, AVG3 BEATS and LPFILTER on 
the SEE of kinetic parameters.   Although the variability might be attributed to Doppler 
measurement errors (Gill, 1985), careful inspection of the velocity waveforms did not reveal any 
loss of signal or noise in the transition phase.  Furthermore, the intra-subject variability for 
kinetics of multiple transitions will not affect our comparison of Beat-by-Beat, AVG3 BEATS and 
LPFILTER for a single transition because the same data set was used for each method. 
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Conclusion 
 
In summary, we have demonstrated that the low-frequency range (≤0.5 Hz) of the power 
spectrum contained the information necessary to describe the kinetics of blood flow, the main 
sources of ‘noise’ in Doppler measurements of blood velocity were muscle contraction and heart 
rate, and that these did not overlap with the frequency spectrum of the biphasic kinetics.  
Moreover, ensemble-averaging several like transitions had an effect qualitatively similar to, but 
less effective than, a low pass filter (i.e., reduce/eliminate high frequency noise).  These 
observations suggest that LPFILTER was a valid procedure to pre-treat blood flow data for kinetics 
analysis.  In this setting, LPFILTER yielded the highest signal-to-noise ratio and temporal 
resolution compared to beat-by-beat data and the average of 3 consecutive beats, which resulted 
in significantly lower standard error of the estimate for all kinetic parameters describing the 
blood flow response.  The direct consequence was a substantial improvement in the 95% 
confidence interval of each kinetic parameter.  
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Table 5.1. Effects of simulated parameters on cutoff frequency for low pass filter. 
  Parameter  Frequency (Hz)  Difference (%) 
τ1 (s)       
  0.5  0.5  0.02 - 7.3 
  1  0.3  0.11 - 5.0 
  2  0.2  0.09 - 3.1 
  3  0.2  0.06 - 1.5 
A1 (% Atot)      
  20  0.2  0.02 - 2.6 
  40  0.2  0.09 - 3.1 
  60  0.2  0.20 - 3.1 
  80  0.2  0.29 - 3.2 
TD2 (s)       
  5  0.3  0.03 - 2.6 
  10  0.2  0.15 - 4.6 
  15  0.2  0.09 - 3.1 
  20  0.2  0.06 - 2.7 
 
Default parameters for simulated blood flow kinetics are BSL = 0.5 a.u., A1 = 2 a.u., A2 = 
3 a.u., τ1 = 2 s, TD2 = 15 s and τ2 = 15 s (see Eq. 1 for definition of parameters).  Atot = A1 + A2. 
Frequency refers to the cutoff frequency of low pass filter necessary to describe the kinetics with 
resulting parameters differing ≤10% of simulated response.  Difference (%) = │(PARSIM –  
PECF)│· 100/PARSIM, where PARSIM is simulated parameter value and PECF is parameter 
estimate determined by curve fitting the filtered response.  Note that these results are 
independent of the absolute values of A1 and A2. 
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Table 5.2. Kinetics parameters of leg blood flow for a single subject. 
   Transitions    
Parameter    1  2  3  4  5  CV (%)   
Ensemble 
average 
BSL (L·min
-1)    0.39 0.40 0.48 0.42 0.45  9.2    0.43 
A1 (L·min
-1)    0.73 0.92 0.76 0.82 0.50  20.9   0.72 
A2 (L·min
-1)    0.37 0.30 0.54 0.40 0.56  25.9   0.42 
EXSS (L·min
-1)    1.48 1.49 1.78 1.61 1.51  8.2    1.56 
τ1 (s)    4.05 10.0 3.23 4.71 1.63  67.0   4.22 
TD2 (s)    22.1 20.0 22.4 16.4 19.8  11.9   20.2 
τ2 (s)    9.0  10.6 24.6 19.9 15.2  40.9   14.7 
MRT (s)    14.5 14.3 22.6 14.4 23.3  26.4   16.5 
MRTRD (s)    14.6 14.6 22.5 14.1 23.3  26.6   16.6 
BSL refers to baseline, A = amplitude, EXSS = exercise steady state, τ = time constant, TD = time delay and MRT = mean 
response time.  Subscripts (1) and (2) indicate each phase of the blood flow response while RD is raw data (200 Hz).  “Ensemble 
average” depicts the kinetic parameters for five transitions ensemble averaged, not the average of parameters shown for transitions 1-
5.  All kinetics descriptions, except for MRTRD, were determined after low pass filtering of the respective data set. 
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Table 5.3. Parameter estimates describing the kinetics of blood flow for a single transition.  
BSL (L·min
-1)  A1 (L·min
-1)  A2 (L·min
-1) 
B-B  AV LPFI B-B AV LPFI B-B AV LPFI
0.39 0.40 0.39 0.44 0.40 0.41 0.19 0.23 0.21
0.39 0.39 0.39 0.42 0.41 0.42 0.43 0.44 0.42
0.41 0.41 0.40 0.58 0.57 0.63 0.55 0.56 0.54
0.38 0.38 0.39 0.65 0.70 0.73 0.46 0.41 0.37
0.39 0.39 0.39  0.52 0.52 0.55  0.41 0.41 0.39 
τ1 (s)  TD2 (s)  τ2 (s) 
B-B  AV LPFI B-B AV LPFI B-B AV LPFI
2.84 1.36 1.72 10.5 6.3 11.1 26.1 31.4 19.5
2.04 1.11 1.36 19.4 18.5 20.7 34.9 36.6 33.1
3.63 3.08 4.78 14.1 13.1 15.2 44.5 46.4 50.3
3.19 3.93 4.04 15.0 19.3 22.0 12.8 9.8  8.9 
2.9 2.4 3.0 14.7  14.3  17.3 29.6  31.0  28.0 
 
Individual results from each method used to pre-process the data from single transitions for kinetics analysis.  B-B = Beat-by-
Beat, AVG3BEATS = average blood flow for three consecutive cardiac cycles, LPFILTER = low pass filter cutoff 0.2 Hz.  Bottom row for 
each parameter is mean (SD). See Table 5.1 for further abbreviations. 
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Table 5.4. Effects of cutoff frequency on kinetics parameters of leg blood flow for five 
transitions ensemble averaged. 
Parameter   Frequency 
    0.2 Hz  0.5 Hz 
    PE (SEE)  % PE  PE (SEE)  % PE 
BSL (L·min
-1)    0.43 (0.002)  0.44  0.42 (0.004)  1.02 
A1 (L·min
-1)   0.72  (0.006)  0.81  0.73 (0.009)  1.24 
A2 (L·min
-1)    0.42 (0.005)  1.23  0.42 (0.007)  1.73 
τ1 (s)    4.22 (0.15)  3.47  4.36 (0.21)  4.71 
TD2 (s)    20.2 (0.27)  1.35  20.0 (0.39)  1.94 
τ2 (s)    14.7 (0.32)  2.14  14.9 (0.44)  2.93 
 
PE = parameter estimate, SEE = standard error of estimate. % PE = SEE·100/PE 
(conceptually similar to coefficient of variation).  See Table 5.2 for abbreviations.  Note that PE 
values are similar when using a cutoff frequency of 0.2 and 0.5 Hz.  Even though the SEE for 0.5 
Hz is slightly greater than for 0.2 Hz the values are very low (< 5%), which is not achieved with 
Beat-by-Beat and AVG3BEATS (see Fig. 5.8). 
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Figure 5.1. Raw data during rest-to-exercise transition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1.  Raw waveforms of lever arm displacement from knee-extension ergometer 
(Ergometer), electrocardiogram (ECG) and blood velocity (converted to blood flow) during the 
rest-to-exercise transition.  At rest, heart beats are the primary source of high-frequency 
oscillations in blood flow whereas during exercise oscillations are determined by the interaction 
between cardiac cycle and muscle contractions.   
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Figure 5.2. Time- and frequency-domain characteristics of simulated blood flow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2. Time- and frequency-domain characteristics of simulated blood flow.  A) 
Simulated blood flow in the time-domain (τ1 = 2 s, TD2 = 15 s, τ2 = 15 s as from Eq. 1).  The 
underlying biphasic increase in blood flow is depicted by the gray line.  Solid (black) line shows 
the simulated response after the oscillatory components (very low frequency, heart rate and 
muscle contraction) and random noise were superimposed on the underlying kinetics.  B) 
Frequency-domain characteristics of simulated blood flow.  Black bars, power spectrum of solid 
(black) line in A; Gray bars, power spectrum of gray line in A.  Inset: Panel (B) with scales 
expanded.  As expected, the very low frequency (6 min
-1; 0.1-Hz), muscle contraction (40 min
-1; 
~ 0.67 Hz) and heart rate (100 bpm; ~ 1.67 Hz) oscillations were retrieved by the frequency 
analysis.  Note that the lower-frequency spectrum (i.e., < 0.1 Hz) contains most of the 
information describing the underlying biphasic response (B, Inset). 
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Figure 5.3. Effects of low-pass filtering on the kinetics of simulated blood flow.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.  Effects of low-pass filtering on the kinetics of simulated blood flow.  
Filtering data with frequencies greater than 0.1 Hz distorted the early increase in blood flow and 
the Phase 1-Phase 2 transition.  The underlying kinetics of blood flow (τ1 = 2 s, TD2 = 15 s, τ2 = 
15 s as from Eq. 1) were preserved by low-pass filtering with a cutoff frequency = 0.2 Hz.  Inset, 
scales expanded to facilitate visualization of the effects of LPFILTER on the rest-to-exercise 
(bottom inset) and Phase 1-to-Phase 2 transitions (top inset).   
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Figure 5.4. Time- and frequency-domain characteristics of raw Doppler data.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4  Time- and frequency-domain characteristics of raw Doppler data.  A) Leg 
blood flow (LBF) in the time-domain (sampling frequency 200-Hz).  Dotted line, LBF of a 
single transition.  Solid line, LBF of 5 transitions ensemble-averaged.  Note the similarity 
between Doppler measurements and simulated response (Fig. 5.1A) and the increase in signal-to-
noise ratio when several transitions are averaged.  B) Power spectral density (PSD) of responses 
shown in A.  Black bars, power spectrum of a single transition (dotted line in A); Gray bars, 
power spectrum of 5 transitions ensemble-averaged (solid line in A).  Inset: Panel (B) with scales 
expanded.  The main sources of ‘noise’ (oscillations) on the Doppler LBF data were muscle 
contraction (40 min
-1; ~ 0.67 Hz) and heart rate [60-90 bpm; ~ 1.0 - 1.5 Hz (from rest-to- 
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exercise)].  Other higher frequency components reflect the harmonics of the fundamental 
frequencies of contraction and heart rate.  Note that the primary effect of ensemble-averaging 
was a reduction in the ‘noise’ present at frequencies greater than 0.1 Hz, while the power at 
frequencies <0.1 Hz is relatively similar to those of a single transition (B, Inset). 
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Figure 5.5. Power spectral density of leg blood flow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5.  Power spectral density (PSD) of leg blood flow response to five transitions 
to the same work rate by one subject.  Note that the power spectral characteristics are 
qualitatively similar for each transition.  The kinetic parameters for these transitions are shown in 
Table 5.1.  
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Figure 5.6. Representative leg blood flow response (5 transitions averaged). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.6.  Leg blood flow response in one subject for five rest-to-exercise transitions 
ensemble-averaged.  A) Raw Doppler blood flow data (sampling frequency 200 Hz) (solid line) 
and after low-pass filter (LPFILTER; gray line).  B) Raw Doppler data shown in (A) after LPFILTER 
and resampled at 10 Hz (Dashed Line).  C) Beat-by-Beat blood flow data (10 Hz interpolated 
and ensemble averaged).  In (B) and (C), solid line represents the best regression fit.  The Beat-
by-Beat (10 Hz interpolated) procedure substantially reduces the noise compared to the raw data 
(solid line in A); however, the signal-to-noise ratio is not optimal for kinetics analysis.  The 
improvement in signal-to-noise ratio is noticeable for LPFILTER where the standard deviation 
(‘noise’) of steady state blood flow was reduced by ~ 85 % compared to Beat-by-Beat. 
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Figure 5.7. Representative leg blood flow response (1 transition). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.7.  Leg blood flow response for a single transition of a representative subject.  
(A) Beat-by-Beat, (B) Average of 3 beats (AVG3 BEATS), and (C) low-pass filter (LPFILTER).  Solid 
line, best regression fit of each response.  AVG3 BEATS reduced the noise at the expense of 
decreasing the data density, which is equivalent to a lower sampling frequency.  In contrast, 
LPFILTER produced the lowest noise with highest temporal resolution.  The consequences of these 
effects on kinetics analysis are shown in Fig. 5.8.  
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Figure 5.8. Results of SEE for each parameter describing the kinetics of blood flow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8.  Standard error of the estimate (SEE) for each parameter describing the 
kinetics of blood flow when using three methods for pre-processing the data of single transitions 
for 4 subjects.  Parameters are from Eq. 1 where A = amplitude, τ = time constant, and TD = 
time delay of each phase of the blood flow response.  AVG3 BEATS = average of 3 consecutive 
heart beats, LPFILTER = low pass filter (cutoff frequency = 0.2 Hz).  *Significantly different (P < 
0.05) from Beat-by-Beat.  
§ Significantly different from AVG3 BEATS (P < 0.01).  Note that 
LPFILTER dramatically reduces the SEE for each parameter, and therefore improves the 
confidence for determining the kinetics of blood flow. 
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CHAPTER 6 - Conclusions 
Integrating the studies described in this dissertation, we conclude that the dynamics of 
muscle O2 delivery are similar to the kinetics of muscle O2 uptake following the onset of exercise 
based on both computer simulations and in vivo estimates.  Moreover, our studies demonstrated 
that the temporal profile of muscle microvascular oxygenation (or microvascular O2 pressure) is 
determined by the interaction of a biphasic increase in O2 delivery and a monoexponential 
kinetics of O2 uptake.  Specifically, the early (first 15-20 s) rapid increase in O2 delivery is 
mandatory to maintain an elevated driving force for capillary-myocyte O2 transfer during the 
period when O2 uptake is increasing at its fastest rate.  Nitric oxide is an essential component of 
this response, where diminished nitric oxide availability speeded the dynamics of microvascular 
O2 pressure causing a decrease to substantially lower values, resembling downregulatory or 
pathological responses seen in aging and chronic diseases, that may impair capillary gas 
exchange.  Altogether our results emphasize the importance of characterizing the kinetics of 
blood flow, specially the initial phase, with good confidence in order to understand the 
mechanisms which govern the dynamic matching of O2 delivery and uptake during exercise. 
Application of a low-pass filter to Doppler blood flow data improved the signal-to-noise ratio 
yielding narrow confidence intervals of parameter estimates that are necessary to draw definitive 
conclusions regarding putative mechanisms controlling blood flow (or O2 delivery) kinetics. 
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